accession	library_ID	title	library_strategy	library_source	library_selection	library_layout	platform	instrument_model	design_description	filetype	filename
SAMN34331443	E1504_11_1_3_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_11_1_3_1_D06.fq.gz
SAMN34331444	E1504_11_1_3_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_11_1_3_1_D07.fq.gz
SAMN34331445	E1504_11_1_3_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_11_1_3_1_D08.fq.gz
SAMN34331446	E1504_11_1_3_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_11_1_3_1_D09.fq.gz
SAMN34331447	E1504_11_1_3_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_11_1_3_1_D10.fq.gz
SAMN34331448	E1504_11_1_3_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_11_1_3_1_D11.fq.gz
SAMN34331278	E1504_11_1_3_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_11_1_3_1_D12.fq.gz
SAMN34331245	E1504_11_1_3_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_11_1_3_1_E01.fq.gz
SAMN34331449	E1504_11_1_3_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_11_1_3_1_E02.fq.gz
SAMN34331450	E1504_11_1_3_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_11_1_3_1_E03.fq.gz
SAMN34331451	E1504_11_1_3_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_11_1_3_1_E04.fq.gz
SAMN34331452	E1504_11_1_3_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_11_1_3_1_E05.fq.gz
SAMN34331453	E1504_11_1_3_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_11_1_3_1_E06.fq.gz
SAMN34331454	E1504_11_1_3_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_11_1_3_1_E07.fq.gz
SAMN34331455	E1504_11_1_3_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_11_1_3_1_E08.fq.gz
SAMN34331456	E1504_11_1_3_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_11_1_3_1_E09.fq.gz
SAMN34331457	E1504_11_1_3_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_11_1_3_1_E10.fq.gz
SAMN34331458	E1504_11_1_3_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_11_1_3_1_E11.fq.gz
SAMN34331245	E1504_11_1_3_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_11_1_3_1_E12.fq.gz
SAMN34331256	E1504_11_1_3_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_11_1_3_1_F01.fq.gz
SAMN34331459	E1504_11_1_3_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_11_1_3_1_F02.fq.gz
SAMN34331460	E1504_11_1_3_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_11_1_3_1_F03.fq.gz
SAMN34331461	E1504_11_1_3_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_11_1_3_1_F04.fq.gz
SAMN34331462	E1504_11_1_3_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_11_1_3_1_F05.fq.gz
SAMN34331463	E1504_11_1_3_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_11_1_3_1_F06.fq.gz
SAMN34331464	E1504_11_1_3_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_11_1_3_1_F07.fq.gz
SAMN34331465	E1504_11_1_3_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_11_1_3_1_F08.fq.gz
SAMN34331466	E1504_11_1_3_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_11_1_3_1_F09.fq.gz
SAMN34331467	E1504_11_1_3_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_11_1_3_1_F10.fq.gz
SAMN34331468	E1504_11_1_3_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_11_1_3_1_F11.fq.gz
SAMN34331256	E1504_11_1_3_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_11_1_3_1_F12.fq.gz
SAMN34331267	E1504_11_1_3_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_11_1_3_1_G01.fq.gz
SAMN34331469	E1504_11_1_3_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_11_1_3_1_G02.fq.gz
SAMN34331470	E1504_11_1_3_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_11_1_3_1_G03.fq.gz
SAMN34331471	E1504_11_1_3_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_11_1_3_1_G04.fq.gz
SAMN34331472	E1504_11_1_3_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_11_1_3_1_G05.fq.gz
SAMN34331473	E1504_11_1_3_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_11_1_3_1_G06.fq.gz
SAMN34331474	E1504_11_1_3_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_11_1_3_1_G07.fq.gz
SAMN34331475	E1504_11_1_3_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_11_1_3_1_G08.fq.gz
SAMN34331476	E1504_11_1_3_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_11_1_3_1_G09.fq.gz
SAMN34331477	E1504_11_1_3_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_11_1_3_1_G10.fq.gz
SAMN34331478	E1504_11_1_3_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_11_1_3_1_G11.fq.gz
SAMN34331267	E1504_11_1_3_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_11_1_3_1_G12.fq.gz
SAMN34331278	E1504_11_1_3_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_11_1_3_1_H01.fq.gz
SAMN34331479	E1504_11_1_3_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_11_1_3_1_H02.fq.gz
SAMN34331480	E1504_11_1_3_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_11_1_3_1_H03.fq.gz
SAMN34331481	E1504_11_1_3_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_11_1_3_1_H04.fq.gz
SAMN34331482	E1504_11_1_3_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_11_1_3_1_H05.fq.gz
SAMN34331483	E1504_11_1_3_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_11_1_3_1_H06.fq.gz
SAMN34331484	E1504_11_1_3_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_11_1_3_1_H07.fq.gz
SAMN34331485	E1504_11_1_3_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_11_1_3_1_H08.fq.gz
SAMN34331486	E1504_11_1_3_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_11_1_3_1_H09.fq.gz
SAMN34331487	E1504_11_1_3_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_11_1_3_1_H10.fq.gz
SAMN34331488	E1504_11_1_3_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_11_1_3_1_H11.fq.gz
SAMN34331278	E1504_11_1_3_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_11_1_3_1_H12.fq.gz
SAMN34331245	E1504_12_1_3_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_1_E1504_01_100_1_1_A01_ACAAGCTA_E1504_12_1_3_2_A01.fq.gz
SAMN34331489	E1504_12_1_3_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_2_E1504_01_100_1_1_A02_AAACATCG_E1504_12_1_3_2_A02.fq.gz
SAMN34331490	E1504_12_1_3_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_3_E1504_01_100_1_1_A03_ACATTGGC_E1504_12_1_3_2_A03.fq.gz
SAMN34331491	E1504_12_1_3_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_4_E1504_01_100_1_1_A04_ACCACTGT_E1504_12_1_3_2_A04.fq.gz
SAMN34331492	E1504_12_1_3_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_5_E1504_01_100_1_1_A05_AACGTGAT_E1504_12_1_3_2_A05.fq.gz
SAMN34331493	E1504_12_1_3_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_6_E1504_01_100_1_1_A06_CGCTGATC_E1504_12_1_3_2_A06.fq.gz
SAMN34331494	E1504_12_1_3_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_7_E1504_01_100_1_1_A07_CAGATCTG_E1504_12_1_3_2_A07.fq.gz
SAMN34331495	E1504_12_1_3_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_8_E1504_01_100_1_1_A08_ATGCCTAA_E1504_12_1_3_2_A08.fq.gz
SAMN34331496	E1504_12_1_3_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_9_E1504_01_100_1_1_A09_CTGTAGCC_E1504_12_1_3_2_A09.fq.gz
SAMN34331497	E1504_12_1_3_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_10_E1504_01_100_1_1_A10_AGTACAAG_E1504_12_1_3_2_A10.fq.gz
SAMN34331498	E1504_12_1_3_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_11_E1504_01_100_1_1_A11_CATCAAGT_E1504_12_1_3_2_A11.fq.gz
SAMN34331245	E1504_12_1_3_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_12_E1504_01_100_1_1_A12_AGTGGTCA_E1504_12_1_3_2_A12.fq.gz
SAMN34331256	E1504_12_1_3_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_13_E1504_01_100_1_1_B01_AACAACCA_E1504_12_1_3_2_B01.fq.gz
SAMN34331499	E1504_12_1_3_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_14_E1504_01_100_1_1_B02_AACCGAGA_E1504_12_1_3_2_B02.fq.gz
SAMN34331500	E1504_12_1_3_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_15_E1504_01_100_1_1_B03_AACGCTTA_E1504_12_1_3_2_B03.fq.gz
SAMN34331501	E1504_12_1_3_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_16_E1504_01_100_1_1_B04_AAGACGGA_E1504_12_1_3_2_B04.fq.gz
SAMN34331502	E1504_12_1_3_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_17_E1504_01_100_1_1_B05_AAGGTACA_E1504_12_1_3_2_B05.fq.gz
SAMN34331503	E1504_12_1_3_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_18_E1504_01_100_1_1_B06_ACACAGAA_E1504_12_1_3_2_B06.fq.gz
SAMN34331504	E1504_12_1_3_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_19_E1504_01_100_1_1_B07_ACAGCAGA_E1504_12_1_3_2_B07.fq.gz
SAMN34331505	E1504_12_1_3_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_20_E1504_01_100_1_1_B08_ACCTCCAA_E1504_12_1_3_2_B08.fq.gz
SAMN34331506	E1504_12_1_3_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_21_E1504_01_100_1_1_B09_ACGCTCGA_E1504_12_1_3_2_B09.fq.gz
SAMN34331507	E1504_12_1_3_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_22_E1504_01_100_1_1_B10_ACGTATCA_E1504_12_1_3_2_B10.fq.gz
SAMN34331508	E1504_12_1_3_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_23_E1504_01_100_1_1_B11_ACTATGCA_E1504_12_1_3_2_B11.fq.gz
SAMN34331256	E1504_12_1_3_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_24_E1504_01_100_1_1_B12_AGAGTCAA_E1504_12_1_3_2_B12.fq.gz
SAMN34331267	E1504_12_1_3_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_25_E1504_01_100_1_1_C01_AGATCGCA_E1504_12_1_3_2_C01.fq.gz
SAMN34331509	E1504_12_1_3_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_26_E1504_01_100_1_1_C02_AGCAGGAA_E1504_12_1_3_2_C02.fq.gz
SAMN34331510	E1504_12_1_3_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_27_E1504_01_100_1_1_C03_AGTCACTA_E1504_12_1_3_2_C03.fq.gz
SAMN34331511	E1504_12_1_3_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_28_E1504_01_100_1_1_C04_ATCCTGTA_E1504_12_1_3_2_C04.fq.gz
SAMN34331512	E1504_12_1_3_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_29_E1504_01_100_1_1_C05_ATTGAGGA_E1504_12_1_3_2_C05.fq.gz
SAMN34331513	E1504_12_1_3_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_30_E1504_01_100_1_1_C06_CAACCACA_E1504_12_1_3_2_C06.fq.gz
SAMN34331514	E1504_12_1_3_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_31_E1504_01_100_1_1_C07_CAAGACTA_E1504_12_1_3_2_C07.fq.gz
SAMN34331515	E1504_12_1_3_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_32_E1504_01_100_1_1_C08_CAATGGAA_E1504_12_1_3_2_C08.fq.gz
SAMN34331516	E1504_12_1_3_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_33_E1504_01_100_1_1_C09_CACTTCGA_E1504_12_1_3_2_C09.fq.gz
SAMN34331517	E1504_12_1_3_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_34_E1504_01_100_1_1_C10_CAGCGTTA_E1504_12_1_3_2_C10.fq.gz
SAMN34331518	E1504_12_1_3_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_35_E1504_01_100_1_1_C11_CATACCAA_E1504_12_1_3_2_C11.fq.gz
SAMN34331267	E1504_12_1_3_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_36_E1504_01_100_1_1_C12_CCAGTTCA_E1504_12_1_3_2_C12.fq.gz
SAMN34331278	E1504_12_1_3_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_37_E1504_01_100_1_1_D01_CCGAAGTA_E1504_12_1_3_2_D01.fq.gz
SAMN34331519	E1504_12_1_3_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_38_E1504_01_100_1_1_D02_CCGTGAGA_E1504_12_1_3_2_D02.fq.gz
SAMN34331520	E1504_12_1_3_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_39_E1504_01_100_1_1_D03_CCTCCTGA_E1504_12_1_3_2_D03.fq.gz
SAMN34331521	E1504_12_1_3_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_40_E1504_01_100_1_1_D04_CGAACTTA_E1504_12_1_3_2_D04.fq.gz
SAMN34331522	E1504_12_1_3_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_41_E1504_01_100_1_1_D05_CGACTGGA_E1504_12_1_3_2_D05.fq.gz
SAMN34331523	E1504_12_1_3_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_12_1_3_2_D06.fq.gz
SAMN34331524	E1504_12_1_3_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_12_1_3_2_D07.fq.gz
SAMN34331525	E1504_12_1_3_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_12_1_3_2_D08.fq.gz
SAMN34331526	E1504_12_1_3_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_12_1_3_2_D09.fq.gz
SAMN34331527	E1504_12_1_3_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_12_1_3_2_D10.fq.gz
SAMN34331528	E1504_12_1_3_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_12_1_3_2_D11.fq.gz
SAMN34331278	E1504_12_1_3_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_12_1_3_2_D12.fq.gz
SAMN34331245	E1504_12_1_3_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_12_1_3_2_E01.fq.gz
SAMN34331529	E1504_12_1_3_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_12_1_3_2_E02.fq.gz
SAMN34331530	E1504_12_1_3_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_12_1_3_2_E03.fq.gz
SAMN34331531	E1504_12_1_3_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_12_1_3_2_E04.fq.gz
SAMN34331532	E1504_12_1_3_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_12_1_3_2_E05.fq.gz
SAMN34331533	E1504_12_1_3_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_12_1_3_2_E06.fq.gz
SAMN34331534	E1504_12_1_3_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_12_1_3_2_E07.fq.gz
SAMN34331535	E1504_12_1_3_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_12_1_3_2_E08.fq.gz
SAMN34331536	E1504_12_1_3_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_12_1_3_2_E09.fq.gz
SAMN34331537	E1504_12_1_3_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_12_1_3_2_E10.fq.gz
SAMN34331538	E1504_12_1_3_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_12_1_3_2_E11.fq.gz
SAMN34331245	E1504_12_1_3_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_12_1_3_2_E12.fq.gz
SAMN34331256	E1504_12_1_3_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_12_1_3_2_F01.fq.gz
SAMN34331539	E1504_12_1_3_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_12_1_3_2_F02.fq.gz
SAMN34331540	E1504_12_1_3_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_12_1_3_2_F03.fq.gz
SAMN34331541	E1504_12_1_3_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_12_1_3_2_F04.fq.gz
SAMN34331542	E1504_12_1_3_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_12_1_3_2_F05.fq.gz
SAMN34331543	E1504_12_1_3_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_12_1_3_2_F06.fq.gz
SAMN34331544	E1504_12_1_3_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_12_1_3_2_F07.fq.gz
SAMN34331545	E1504_12_1_3_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_12_1_3_2_F08.fq.gz
SAMN34331546	E1504_12_1_3_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_12_1_3_2_F09.fq.gz
SAMN34331547	E1504_12_1_3_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_12_1_3_2_F10.fq.gz
SAMN34331548	E1504_12_1_3_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_12_1_3_2_F11.fq.gz
SAMN34331256	E1504_12_1_3_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_12_1_3_2_F12.fq.gz
SAMN34331267	E1504_12_1_3_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_12_1_3_2_G01.fq.gz
SAMN34331549	E1504_12_1_3_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_12_1_3_2_G02.fq.gz
SAMN34331550	E1504_12_1_3_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_12_1_3_2_G03.fq.gz
SAMN34331551	E1504_12_1_3_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_12_1_3_2_G04.fq.gz
SAMN34331552	E1504_12_1_3_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_12_1_3_2_G05.fq.gz
SAMN34331553	E1504_12_1_3_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_12_1_3_2_G06.fq.gz
SAMN34331554	E1504_12_1_3_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_12_1_3_2_G07.fq.gz
SAMN34331555	E1504_12_1_3_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_12_1_3_2_G08.fq.gz
SAMN34331556	E1504_12_1_3_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_12_1_3_2_G09.fq.gz
SAMN34331557	E1504_12_1_3_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_12_1_3_2_G10.fq.gz
SAMN34331558	E1504_12_1_3_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_12_1_3_2_G11.fq.gz
SAMN34331267	E1504_12_1_3_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_12_1_3_2_G12.fq.gz
SAMN34331278	E1504_12_1_3_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_12_1_3_2_H01.fq.gz
SAMN34331559	E1504_12_1_3_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_12_1_3_2_H02.fq.gz
SAMN34331560	E1504_12_1_3_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_12_1_3_2_H03.fq.gz
SAMN34331561	E1504_12_1_3_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_12_1_3_2_H04.fq.gz
SAMN34331562	E1504_12_1_3_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_12_1_3_2_H05.fq.gz
SAMN34331563	E1504_12_1_3_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_12_1_3_2_H06.fq.gz
SAMN34331564	E1504_12_1_3_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_12_1_3_2_H07.fq.gz
SAMN34331565	E1504_12_1_3_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_12_1_3_2_H08.fq.gz
SAMN34331566	E1504_12_1_3_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_12_1_3_2_H09.fq.gz
SAMN34331567	E1504_12_1_3_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_12_1_3_2_H10.fq.gz
SAMN34331568	E1504_12_1_3_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_12_1_3_2_H11.fq.gz
SAMN34331278	E1504_12_1_3_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_12_1_3_2_H12.fq.gz
SAMN34331245	E1504_13_10_1_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_1_E1504_01_100_1_1_A01_ACAAGCTA_E1504_13_10_1_1_A01.fq.gz
SAMN34331569	E1504_13_10_1_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_2_E1504_01_100_1_1_A02_AAACATCG_E1504_13_10_1_1_A02.fq.gz
SAMN34331570	E1504_13_10_1_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_3_E1504_01_100_1_1_A03_ACATTGGC_E1504_13_10_1_1_A03.fq.gz
SAMN34331571	E1504_13_10_1_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_4_E1504_01_100_1_1_A04_ACCACTGT_E1504_13_10_1_1_A04.fq.gz
SAMN34331572	E1504_13_10_1_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_5_E1504_01_100_1_1_A05_AACGTGAT_E1504_13_10_1_1_A05.fq.gz
SAMN34331573	E1504_13_10_1_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_6_E1504_01_100_1_1_A06_CGCTGATC_E1504_13_10_1_1_A06.fq.gz
SAMN34331574	E1504_13_10_1_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_7_E1504_01_100_1_1_A07_CAGATCTG_E1504_13_10_1_1_A07.fq.gz
SAMN34331575	E1504_13_10_1_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_8_E1504_01_100_1_1_A08_ATGCCTAA_E1504_13_10_1_1_A08.fq.gz
SAMN34331576	E1504_13_10_1_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_9_E1504_01_100_1_1_A09_CTGTAGCC_E1504_13_10_1_1_A09.fq.gz
SAMN34331577	E1504_13_10_1_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_10_E1504_01_100_1_1_A10_AGTACAAG_E1504_13_10_1_1_A10.fq.gz
SAMN34331578	E1504_13_10_1_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_11_E1504_01_100_1_1_A11_CATCAAGT_E1504_13_10_1_1_A11.fq.gz
SAMN34331245	E1504_13_10_1_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_12_E1504_01_100_1_1_A12_AGTGGTCA_E1504_13_10_1_1_A12.fq.gz
SAMN34331256	E1504_13_10_1_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_13_E1504_01_100_1_1_B01_AACAACCA_E1504_13_10_1_1_B01.fq.gz
SAMN34331579	E1504_13_10_1_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_14_E1504_01_100_1_1_B02_AACCGAGA_E1504_13_10_1_1_B02.fq.gz
SAMN34331580	E1504_13_10_1_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_15_E1504_01_100_1_1_B03_AACGCTTA_E1504_13_10_1_1_B03.fq.gz
SAMN34331581	E1504_13_10_1_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_16_E1504_01_100_1_1_B04_AAGACGGA_E1504_13_10_1_1_B04.fq.gz
SAMN34331582	E1504_13_10_1_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_17_E1504_01_100_1_1_B05_AAGGTACA_E1504_13_10_1_1_B05.fq.gz
SAMN34331583	E1504_13_10_1_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_18_E1504_01_100_1_1_B06_ACACAGAA_E1504_13_10_1_1_B06.fq.gz
SAMN34331584	E1504_13_10_1_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_19_E1504_01_100_1_1_B07_ACAGCAGA_E1504_13_10_1_1_B07.fq.gz
SAMN34331585	E1504_13_10_1_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_20_E1504_01_100_1_1_B08_ACCTCCAA_E1504_13_10_1_1_B08.fq.gz
SAMN34331586	E1504_13_10_1_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_21_E1504_01_100_1_1_B09_ACGCTCGA_E1504_13_10_1_1_B09.fq.gz
SAMN34331587	E1504_13_10_1_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_22_E1504_01_100_1_1_B10_ACGTATCA_E1504_13_10_1_1_B10.fq.gz
SAMN34331588	E1504_13_10_1_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_23_E1504_01_100_1_1_B11_ACTATGCA_E1504_13_10_1_1_B11.fq.gz
SAMN34331256	E1504_13_10_1_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_24_E1504_01_100_1_1_B12_AGAGTCAA_E1504_13_10_1_1_B12.fq.gz
SAMN34331267	E1504_13_10_1_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_25_E1504_01_100_1_1_C01_AGATCGCA_E1504_13_10_1_1_C01.fq.gz
SAMN34331589	E1504_13_10_1_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_26_E1504_01_100_1_1_C02_AGCAGGAA_E1504_13_10_1_1_C02.fq.gz
SAMN34331590	E1504_13_10_1_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_27_E1504_01_100_1_1_C03_AGTCACTA_E1504_13_10_1_1_C03.fq.gz
SAMN34331591	E1504_13_10_1_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_28_E1504_01_100_1_1_C04_ATCCTGTA_E1504_13_10_1_1_C04.fq.gz
SAMN34331592	E1504_13_10_1_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_29_E1504_01_100_1_1_C05_ATTGAGGA_E1504_13_10_1_1_C05.fq.gz
SAMN34331593	E1504_13_10_1_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_30_E1504_01_100_1_1_C06_CAACCACA_E1504_13_10_1_1_C06.fq.gz
SAMN34331594	E1504_13_10_1_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_31_E1504_01_100_1_1_C07_CAAGACTA_E1504_13_10_1_1_C07.fq.gz
SAMN34331595	E1504_13_10_1_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_32_E1504_01_100_1_1_C08_CAATGGAA_E1504_13_10_1_1_C08.fq.gz
SAMN34331596	E1504_13_10_1_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_33_E1504_01_100_1_1_C09_CACTTCGA_E1504_13_10_1_1_C09.fq.gz
SAMN34331597	E1504_13_10_1_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_34_E1504_01_100_1_1_C10_CAGCGTTA_E1504_13_10_1_1_C10.fq.gz
SAMN34331598	E1504_13_10_1_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_35_E1504_01_100_1_1_C11_CATACCAA_E1504_13_10_1_1_C11.fq.gz
SAMN34331267	E1504_13_10_1_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_36_E1504_01_100_1_1_C12_CCAGTTCA_E1504_13_10_1_1_C12.fq.gz
SAMN34331278	E1504_13_10_1_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_37_E1504_01_100_1_1_D01_CCGAAGTA_E1504_13_10_1_1_D01.fq.gz
SAMN34331599	E1504_13_10_1_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_38_E1504_01_100_1_1_D02_CCGTGAGA_E1504_13_10_1_1_D02.fq.gz
SAMN34331600	E1504_13_10_1_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_39_E1504_01_100_1_1_D03_CCTCCTGA_E1504_13_10_1_1_D03.fq.gz
SAMN34331601	E1504_13_10_1_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_40_E1504_01_100_1_1_D04_CGAACTTA_E1504_13_10_1_1_D04.fq.gz
SAMN34331602	E1504_13_10_1_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_41_E1504_01_100_1_1_D05_CGACTGGA_E1504_13_10_1_1_D05.fq.gz
SAMN34331603	E1504_13_10_1_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_13_10_1_1_D06.fq.gz
SAMN34331604	E1504_13_10_1_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_13_10_1_1_D07.fq.gz
SAMN34331605	E1504_13_10_1_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_13_10_1_1_D08.fq.gz
SAMN34331606	E1504_13_10_1_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_13_10_1_1_D09.fq.gz
SAMN34331607	E1504_13_10_1_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_13_10_1_1_D10.fq.gz
SAMN34331608	E1504_13_10_1_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_13_10_1_1_D11.fq.gz
SAMN34331278	E1504_13_10_1_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_13_10_1_1_D12.fq.gz
SAMN34331245	E1504_13_10_1_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_13_10_1_1_E01.fq.gz
SAMN34331609	E1504_13_10_1_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_13_10_1_1_E02.fq.gz
SAMN34331610	E1504_13_10_1_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_13_10_1_1_E03.fq.gz
SAMN34331611	E1504_13_10_1_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_13_10_1_1_E04.fq.gz
SAMN34331612	E1504_13_10_1_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_13_10_1_1_E05.fq.gz
SAMN34331613	E1504_13_10_1_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_13_10_1_1_E06.fq.gz
SAMN34331614	E1504_13_10_1_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_13_10_1_1_E07.fq.gz
SAMN34331615	E1504_13_10_1_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_13_10_1_1_E08.fq.gz
SAMN34331616	E1504_13_10_1_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_13_10_1_1_E09.fq.gz
SAMN34331617	E1504_13_10_1_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_13_10_1_1_E10.fq.gz
SAMN34331618	E1504_13_10_1_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_13_10_1_1_E11.fq.gz
SAMN34331245	E1504_13_10_1_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_13_10_1_1_E12.fq.gz
SAMN34331256	E1504_13_10_1_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_13_10_1_1_F01.fq.gz
SAMN34331619	E1504_13_10_1_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_13_10_1_1_F02.fq.gz
SAMN34331620	E1504_13_10_1_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_13_10_1_1_F03.fq.gz
SAMN34331621	E1504_13_10_1_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_13_10_1_1_F04.fq.gz
SAMN34331622	E1504_13_10_1_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_13_10_1_1_F05.fq.gz
SAMN34331623	E1504_13_10_1_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_13_10_1_1_F06.fq.gz
SAMN34331624	E1504_13_10_1_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_13_10_1_1_F07.fq.gz
SAMN34331625	E1504_13_10_1_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_13_10_1_1_F08.fq.gz
SAMN34331626	E1504_13_10_1_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_13_10_1_1_F09.fq.gz
SAMN34331627	E1504_13_10_1_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_13_10_1_1_F10.fq.gz
SAMN34331628	E1504_13_10_1_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_13_10_1_1_F11.fq.gz
SAMN34331256	E1504_13_10_1_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_13_10_1_1_F12.fq.gz
SAMN34331267	E1504_13_10_1_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_13_10_1_1_G01.fq.gz
SAMN34331629	E1504_13_10_1_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_13_10_1_1_G02.fq.gz
SAMN34331630	E1504_13_10_1_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_13_10_1_1_G03.fq.gz
SAMN34331631	E1504_13_10_1_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_13_10_1_1_G04.fq.gz
SAMN34331632	E1504_13_10_1_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_13_10_1_1_G05.fq.gz
SAMN34331633	E1504_13_10_1_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_13_10_1_1_G06.fq.gz
SAMN34331634	E1504_13_10_1_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_13_10_1_1_G07.fq.gz
SAMN34331635	E1504_13_10_1_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_13_10_1_1_G08.fq.gz
SAMN34331636	E1504_13_10_1_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_13_10_1_1_G09.fq.gz
SAMN34331637	E1504_13_10_1_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_13_10_1_1_G10.fq.gz
SAMN34331638	E1504_13_10_1_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_13_10_1_1_G11.fq.gz
SAMN34331267	E1504_13_10_1_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_13_10_1_1_G12.fq.gz
SAMN34331278	E1504_13_10_1_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_13_10_1_1_H01.fq.gz
SAMN34331639	E1504_13_10_1_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_13_10_1_1_H02.fq.gz
SAMN34331640	E1504_13_10_1_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_13_10_1_1_H03.fq.gz
SAMN34331641	E1504_13_10_1_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_13_10_1_1_H04.fq.gz
SAMN34331642	E1504_13_10_1_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_13_10_1_1_H05.fq.gz
SAMN34331643	E1504_13_10_1_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_13_10_1_1_H06.fq.gz
SAMN34331644	E1504_13_10_1_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_13_10_1_1_H07.fq.gz
SAMN34331645	E1504_13_10_1_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_13_10_1_1_H08.fq.gz
SAMN34331646	E1504_13_10_1_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_13_10_1_1_H09.fq.gz
SAMN34331647	E1504_13_10_1_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_13_10_1_1_H10.fq.gz
SAMN34331648	E1504_13_10_1_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_13_10_1_1_H11.fq.gz
SAMN34331278	E1504_13_10_1_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_13_10_1_1_H12.fq.gz
SAMN34331245	E1504_14_10_1_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_1_E1504_01_100_1_1_A01_ACAAGCTA_E1504_14_10_1_2_A01.fq.gz
SAMN34331649	E1504_14_10_1_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_2_E1504_01_100_1_1_A02_AAACATCG_E1504_14_10_1_2_A02.fq.gz
SAMN34331650	E1504_14_10_1_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_3_E1504_01_100_1_1_A03_ACATTGGC_E1504_14_10_1_2_A03.fq.gz
SAMN34331651	E1504_14_10_1_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_4_E1504_01_100_1_1_A04_ACCACTGT_E1504_14_10_1_2_A04.fq.gz
SAMN34331652	E1504_14_10_1_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_5_E1504_01_100_1_1_A05_AACGTGAT_E1504_14_10_1_2_A05.fq.gz
SAMN34331653	E1504_14_10_1_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_6_E1504_01_100_1_1_A06_CGCTGATC_E1504_14_10_1_2_A06.fq.gz
SAMN34331654	E1504_14_10_1_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_7_E1504_01_100_1_1_A07_CAGATCTG_E1504_14_10_1_2_A07.fq.gz
SAMN34331655	E1504_14_10_1_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_8_E1504_01_100_1_1_A08_ATGCCTAA_E1504_14_10_1_2_A08.fq.gz
SAMN34331656	E1504_14_10_1_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_9_E1504_01_100_1_1_A09_CTGTAGCC_E1504_14_10_1_2_A09.fq.gz
SAMN34331657	E1504_14_10_1_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_10_E1504_01_100_1_1_A10_AGTACAAG_E1504_14_10_1_2_A10.fq.gz
SAMN34331658	E1504_14_10_1_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_11_E1504_01_100_1_1_A11_CATCAAGT_E1504_14_10_1_2_A11.fq.gz
SAMN34331245	E1504_14_10_1_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_12_E1504_01_100_1_1_A12_AGTGGTCA_E1504_14_10_1_2_A12.fq.gz
SAMN34331256	E1504_14_10_1_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_13_E1504_01_100_1_1_B01_AACAACCA_E1504_14_10_1_2_B01.fq.gz
SAMN34331659	E1504_14_10_1_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_14_E1504_01_100_1_1_B02_AACCGAGA_E1504_14_10_1_2_B02.fq.gz
SAMN34331660	E1504_14_10_1_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_15_E1504_01_100_1_1_B03_AACGCTTA_E1504_14_10_1_2_B03.fq.gz
SAMN34331661	E1504_14_10_1_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_16_E1504_01_100_1_1_B04_AAGACGGA_E1504_14_10_1_2_B04.fq.gz
SAMN34331662	E1504_14_10_1_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_17_E1504_01_100_1_1_B05_AAGGTACA_E1504_14_10_1_2_B05.fq.gz
SAMN34331663	E1504_14_10_1_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_18_E1504_01_100_1_1_B06_ACACAGAA_E1504_14_10_1_2_B06.fq.gz
SAMN34331664	E1504_14_10_1_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_19_E1504_01_100_1_1_B07_ACAGCAGA_E1504_14_10_1_2_B07.fq.gz
SAMN34331665	E1504_14_10_1_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_20_E1504_01_100_1_1_B08_ACCTCCAA_E1504_14_10_1_2_B08.fq.gz
SAMN34331666	E1504_14_10_1_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_21_E1504_01_100_1_1_B09_ACGCTCGA_E1504_14_10_1_2_B09.fq.gz
SAMN34331667	E1504_14_10_1_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_22_E1504_01_100_1_1_B10_ACGTATCA_E1504_14_10_1_2_B10.fq.gz
SAMN34331668	E1504_14_10_1_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_23_E1504_01_100_1_1_B11_ACTATGCA_E1504_14_10_1_2_B11.fq.gz
SAMN34331256	E1504_14_10_1_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_24_E1504_01_100_1_1_B12_AGAGTCAA_E1504_14_10_1_2_B12.fq.gz
SAMN34331267	E1504_14_10_1_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_25_E1504_01_100_1_1_C01_AGATCGCA_E1504_14_10_1_2_C01.fq.gz
SAMN34331669	E1504_14_10_1_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_26_E1504_01_100_1_1_C02_AGCAGGAA_E1504_14_10_1_2_C02.fq.gz
SAMN34331670	E1504_14_10_1_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_27_E1504_01_100_1_1_C03_AGTCACTA_E1504_14_10_1_2_C03.fq.gz
SAMN34331671	E1504_14_10_1_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_28_E1504_01_100_1_1_C04_ATCCTGTA_E1504_14_10_1_2_C04.fq.gz
SAMN34331672	E1504_14_10_1_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_29_E1504_01_100_1_1_C05_ATTGAGGA_E1504_14_10_1_2_C05.fq.gz
SAMN34331673	E1504_14_10_1_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_30_E1504_01_100_1_1_C06_CAACCACA_E1504_14_10_1_2_C06.fq.gz
SAMN34331674	E1504_14_10_1_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_31_E1504_01_100_1_1_C07_CAAGACTA_E1504_14_10_1_2_C07.fq.gz
SAMN34331675	E1504_14_10_1_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_32_E1504_01_100_1_1_C08_CAATGGAA_E1504_14_10_1_2_C08.fq.gz
SAMN34331676	E1504_14_10_1_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_33_E1504_01_100_1_1_C09_CACTTCGA_E1504_14_10_1_2_C09.fq.gz
SAMN34331677	E1504_14_10_1_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_34_E1504_01_100_1_1_C10_CAGCGTTA_E1504_14_10_1_2_C10.fq.gz
SAMN34331678	E1504_14_10_1_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_35_E1504_01_100_1_1_C11_CATACCAA_E1504_14_10_1_2_C11.fq.gz
SAMN34331267	E1504_14_10_1_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_36_E1504_01_100_1_1_C12_CCAGTTCA_E1504_14_10_1_2_C12.fq.gz
SAMN34331278	E1504_14_10_1_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_37_E1504_01_100_1_1_D01_CCGAAGTA_E1504_14_10_1_2_D01.fq.gz
SAMN34331679	E1504_14_10_1_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_38_E1504_01_100_1_1_D02_CCGTGAGA_E1504_14_10_1_2_D02.fq.gz
SAMN34331680	E1504_14_10_1_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_39_E1504_01_100_1_1_D03_CCTCCTGA_E1504_14_10_1_2_D03.fq.gz
SAMN34331681	E1504_14_10_1_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_40_E1504_01_100_1_1_D04_CGAACTTA_E1504_14_10_1_2_D04.fq.gz
SAMN34331682	E1504_14_10_1_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_41_E1504_01_100_1_1_D05_CGACTGGA_E1504_14_10_1_2_D05.fq.gz
SAMN34331683	E1504_14_10_1_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_14_10_1_2_D06.fq.gz
SAMN34331684	E1504_14_10_1_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_14_10_1_2_D07.fq.gz
SAMN34331685	E1504_14_10_1_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_14_10_1_2_D08.fq.gz
SAMN34331686	E1504_14_10_1_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_14_10_1_2_D09.fq.gz
SAMN34331687	E1504_14_10_1_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_14_10_1_2_D10.fq.gz
SAMN34331688	E1504_14_10_1_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_14_10_1_2_D11.fq.gz
SAMN34331278	E1504_14_10_1_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_14_10_1_2_D12.fq.gz
SAMN34331245	E1504_14_10_1_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_14_10_1_2_E01.fq.gz
SAMN34331689	E1504_14_10_1_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_14_10_1_2_E02.fq.gz
SAMN34331690	E1504_14_10_1_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_14_10_1_2_E03.fq.gz
SAMN34331691	E1504_14_10_1_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_14_10_1_2_E04.fq.gz
SAMN34331692	E1504_14_10_1_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_14_10_1_2_E05.fq.gz
SAMN34331693	E1504_14_10_1_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_14_10_1_2_E06.fq.gz
SAMN34331694	E1504_14_10_1_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_14_10_1_2_E07.fq.gz
SAMN34331695	E1504_14_10_1_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_14_10_1_2_E08.fq.gz
SAMN34331696	E1504_14_10_1_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_14_10_1_2_E09.fq.gz
SAMN34331697	E1504_14_10_1_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_14_10_1_2_E10.fq.gz
SAMN34331698	E1504_14_10_1_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_14_10_1_2_E11.fq.gz
SAMN34331245	E1504_14_10_1_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_14_10_1_2_E12.fq.gz
SAMN34331256	E1504_14_10_1_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_14_10_1_2_F01.fq.gz
SAMN34331699	E1504_14_10_1_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_14_10_1_2_F02.fq.gz
SAMN34331700	E1504_14_10_1_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_14_10_1_2_F03.fq.gz
SAMN34331701	E1504_14_10_1_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_14_10_1_2_F04.fq.gz
SAMN34331702	E1504_14_10_1_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_14_10_1_2_F05.fq.gz
SAMN34331703	E1504_14_10_1_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_14_10_1_2_F06.fq.gz
SAMN34331704	E1504_14_10_1_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_14_10_1_2_F07.fq.gz
SAMN34331705	E1504_14_10_1_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_14_10_1_2_F08.fq.gz
SAMN34331706	E1504_14_10_1_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_14_10_1_2_F09.fq.gz
SAMN34331707	E1504_14_10_1_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_14_10_1_2_F10.fq.gz
SAMN34331708	E1504_14_10_1_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_14_10_1_2_F11.fq.gz
SAMN34331256	E1504_14_10_1_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_14_10_1_2_F12.fq.gz
SAMN34331267	E1504_14_10_1_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_14_10_1_2_G01.fq.gz
SAMN34331709	E1504_14_10_1_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_14_10_1_2_G02.fq.gz
SAMN34331710	E1504_14_10_1_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_14_10_1_2_G03.fq.gz
SAMN34331711	E1504_14_10_1_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_14_10_1_2_G04.fq.gz
SAMN34331712	E1504_14_10_1_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_14_10_1_2_G05.fq.gz
SAMN34331713	E1504_14_10_1_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_14_10_1_2_G06.fq.gz
SAMN34331714	E1504_14_10_1_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_14_10_1_2_G07.fq.gz
SAMN34331715	E1504_14_10_1_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_14_10_1_2_G08.fq.gz
SAMN34331716	E1504_14_10_1_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_14_10_1_2_G09.fq.gz
SAMN34331717	E1504_14_10_1_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_14_10_1_2_G10.fq.gz
SAMN34331718	E1504_14_10_1_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_14_10_1_2_G11.fq.gz
SAMN34331267	E1504_14_10_1_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_14_10_1_2_G12.fq.gz
SAMN34331278	E1504_14_10_1_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_14_10_1_2_H01.fq.gz
SAMN34331719	E1504_14_10_1_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_14_10_1_2_H02.fq.gz
SAMN34331720	E1504_14_10_1_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_14_10_1_2_H03.fq.gz
SAMN34331721	E1504_14_10_1_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_14_10_1_2_H04.fq.gz
SAMN34331722	E1504_14_10_1_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_14_10_1_2_H05.fq.gz
SAMN34331723	E1504_14_10_1_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_14_10_1_2_H06.fq.gz
SAMN34331724	E1504_14_10_1_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_14_10_1_2_H07.fq.gz
SAMN34331725	E1504_14_10_1_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_14_10_1_2_H08.fq.gz
SAMN34331726	E1504_14_10_1_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_14_10_1_2_H09.fq.gz
SAMN34331727	E1504_14_10_1_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_14_10_1_2_H10.fq.gz
SAMN34331728	E1504_14_10_1_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_14_10_1_2_H11.fq.gz
SAMN34331278	E1504_14_10_1_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_14_10_1_2_H12.fq.gz
SAMN34331245	E1504_15_10_2_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_1_E1504_01_100_1_1_A01_ACAAGCTA_E1504_15_10_2_1_A01.fq.gz
SAMN34331569	E1504_15_10_2_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_2_E1504_01_100_1_1_A02_AAACATCG_E1504_15_10_2_1_A02.fq.gz
SAMN34331570	E1504_15_10_2_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_3_E1504_01_100_1_1_A03_ACATTGGC_E1504_15_10_2_1_A03.fq.gz
SAMN34331571	E1504_15_10_2_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_4_E1504_01_100_1_1_A04_ACCACTGT_E1504_15_10_2_1_A04.fq.gz
SAMN34331572	E1504_15_10_2_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_5_E1504_01_100_1_1_A05_AACGTGAT_E1504_15_10_2_1_A05.fq.gz
SAMN34331573	E1504_15_10_2_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_6_E1504_01_100_1_1_A06_CGCTGATC_E1504_15_10_2_1_A06.fq.gz
SAMN34331574	E1504_15_10_2_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_7_E1504_01_100_1_1_A07_CAGATCTG_E1504_15_10_2_1_A07.fq.gz
SAMN34331575	E1504_15_10_2_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_8_E1504_01_100_1_1_A08_ATGCCTAA_E1504_15_10_2_1_A08.fq.gz
SAMN34331576	E1504_15_10_2_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_9_E1504_01_100_1_1_A09_CTGTAGCC_E1504_15_10_2_1_A09.fq.gz
SAMN34331577	E1504_15_10_2_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_10_E1504_01_100_1_1_A10_AGTACAAG_E1504_15_10_2_1_A10.fq.gz
SAMN34331578	E1504_15_10_2_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_11_E1504_01_100_1_1_A11_CATCAAGT_E1504_15_10_2_1_A11.fq.gz
SAMN34331245	E1504_15_10_2_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_12_E1504_01_100_1_1_A12_AGTGGTCA_E1504_15_10_2_1_A12.fq.gz
SAMN34331256	E1504_15_10_2_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_13_E1504_01_100_1_1_B01_AACAACCA_E1504_15_10_2_1_B01.fq.gz
SAMN34331579	E1504_15_10_2_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_14_E1504_01_100_1_1_B02_AACCGAGA_E1504_15_10_2_1_B02.fq.gz
SAMN34331580	E1504_15_10_2_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_15_E1504_01_100_1_1_B03_AACGCTTA_E1504_15_10_2_1_B03.fq.gz
SAMN34331581	E1504_15_10_2_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_16_E1504_01_100_1_1_B04_AAGACGGA_E1504_15_10_2_1_B04.fq.gz
SAMN34331582	E1504_15_10_2_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_17_E1504_01_100_1_1_B05_AAGGTACA_E1504_15_10_2_1_B05.fq.gz
SAMN34331583	E1504_15_10_2_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_18_E1504_01_100_1_1_B06_ACACAGAA_E1504_15_10_2_1_B06.fq.gz
SAMN34331584	E1504_15_10_2_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_19_E1504_01_100_1_1_B07_ACAGCAGA_E1504_15_10_2_1_B07.fq.gz
SAMN34331585	E1504_15_10_2_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_20_E1504_01_100_1_1_B08_ACCTCCAA_E1504_15_10_2_1_B08.fq.gz
SAMN34331586	E1504_15_10_2_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_21_E1504_01_100_1_1_B09_ACGCTCGA_E1504_15_10_2_1_B09.fq.gz
SAMN34331587	E1504_15_10_2_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_22_E1504_01_100_1_1_B10_ACGTATCA_E1504_15_10_2_1_B10.fq.gz
SAMN34331588	E1504_15_10_2_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_23_E1504_01_100_1_1_B11_ACTATGCA_E1504_15_10_2_1_B11.fq.gz
SAMN34331256	E1504_15_10_2_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_24_E1504_01_100_1_1_B12_AGAGTCAA_E1504_15_10_2_1_B12.fq.gz
SAMN34331267	E1504_15_10_2_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_25_E1504_01_100_1_1_C01_AGATCGCA_E1504_15_10_2_1_C01.fq.gz
SAMN34331589	E1504_15_10_2_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_26_E1504_01_100_1_1_C02_AGCAGGAA_E1504_15_10_2_1_C02.fq.gz
SAMN34331590	E1504_15_10_2_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_27_E1504_01_100_1_1_C03_AGTCACTA_E1504_15_10_2_1_C03.fq.gz
SAMN34331591	E1504_15_10_2_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_28_E1504_01_100_1_1_C04_ATCCTGTA_E1504_15_10_2_1_C04.fq.gz
SAMN34331592	E1504_15_10_2_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_29_E1504_01_100_1_1_C05_ATTGAGGA_E1504_15_10_2_1_C05.fq.gz
SAMN34331593	E1504_15_10_2_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_30_E1504_01_100_1_1_C06_CAACCACA_E1504_15_10_2_1_C06.fq.gz
SAMN34331594	E1504_15_10_2_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_31_E1504_01_100_1_1_C07_CAAGACTA_E1504_15_10_2_1_C07.fq.gz
SAMN34331595	E1504_15_10_2_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_32_E1504_01_100_1_1_C08_CAATGGAA_E1504_15_10_2_1_C08.fq.gz
SAMN34331596	E1504_15_10_2_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_33_E1504_01_100_1_1_C09_CACTTCGA_E1504_15_10_2_1_C09.fq.gz
SAMN34331597	E1504_15_10_2_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_34_E1504_01_100_1_1_C10_CAGCGTTA_E1504_15_10_2_1_C10.fq.gz
SAMN34331598	E1504_15_10_2_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_35_E1504_01_100_1_1_C11_CATACCAA_E1504_15_10_2_1_C11.fq.gz
SAMN34331267	E1504_15_10_2_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_36_E1504_01_100_1_1_C12_CCAGTTCA_E1504_15_10_2_1_C12.fq.gz
SAMN34331278	E1504_15_10_2_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_37_E1504_01_100_1_1_D01_CCGAAGTA_E1504_15_10_2_1_D01.fq.gz
SAMN34331599	E1504_15_10_2_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_38_E1504_01_100_1_1_D02_CCGTGAGA_E1504_15_10_2_1_D02.fq.gz
SAMN34331600	E1504_15_10_2_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_39_E1504_01_100_1_1_D03_CCTCCTGA_E1504_15_10_2_1_D03.fq.gz
SAMN34331601	E1504_15_10_2_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_40_E1504_01_100_1_1_D04_CGAACTTA_E1504_15_10_2_1_D04.fq.gz
SAMN34331602	E1504_15_10_2_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_41_E1504_01_100_1_1_D05_CGACTGGA_E1504_15_10_2_1_D05.fq.gz
SAMN34331603	E1504_15_10_2_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_15_10_2_1_D06.fq.gz
SAMN34331604	E1504_15_10_2_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_15_10_2_1_D07.fq.gz
SAMN34331605	E1504_15_10_2_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_15_10_2_1_D08.fq.gz
SAMN34331606	E1504_15_10_2_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_15_10_2_1_D09.fq.gz
SAMN34331607	E1504_15_10_2_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_15_10_2_1_D10.fq.gz
SAMN34331608	E1504_15_10_2_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_15_10_2_1_D11.fq.gz
SAMN34331278	E1504_15_10_2_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_15_10_2_1_D12.fq.gz
SAMN34331245	E1504_15_10_2_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_15_10_2_1_E01.fq.gz
SAMN34331609	E1504_15_10_2_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_15_10_2_1_E02.fq.gz
SAMN34331610	E1504_15_10_2_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_15_10_2_1_E03.fq.gz
SAMN34331611	E1504_15_10_2_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_15_10_2_1_E04.fq.gz
SAMN34331612	E1504_15_10_2_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_15_10_2_1_E05.fq.gz
SAMN34331613	E1504_15_10_2_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_15_10_2_1_E06.fq.gz
SAMN34331614	E1504_15_10_2_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_15_10_2_1_E07.fq.gz
SAMN34331615	E1504_15_10_2_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_15_10_2_1_E08.fq.gz
SAMN34331616	E1504_15_10_2_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_15_10_2_1_E09.fq.gz
SAMN34331617	E1504_15_10_2_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_15_10_2_1_E10.fq.gz
SAMN34331618	E1504_15_10_2_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_15_10_2_1_E11.fq.gz
SAMN34331245	E1504_15_10_2_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_15_10_2_1_E12.fq.gz
SAMN34331256	E1504_15_10_2_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_15_10_2_1_F01.fq.gz
SAMN34331619	E1504_15_10_2_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_15_10_2_1_F02.fq.gz
SAMN34331620	E1504_15_10_2_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_15_10_2_1_F03.fq.gz
SAMN34331621	E1504_15_10_2_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_15_10_2_1_F04.fq.gz
SAMN34331622	E1504_15_10_2_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_15_10_2_1_F05.fq.gz
SAMN34331623	E1504_15_10_2_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_15_10_2_1_F06.fq.gz
SAMN34331624	E1504_15_10_2_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_15_10_2_1_F07.fq.gz
SAMN34331625	E1504_15_10_2_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_15_10_2_1_F08.fq.gz
SAMN34331626	E1504_15_10_2_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_15_10_2_1_F09.fq.gz
SAMN34331627	E1504_15_10_2_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_15_10_2_1_F10.fq.gz
SAMN34331628	E1504_15_10_2_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_15_10_2_1_F11.fq.gz
SAMN34331256	E1504_15_10_2_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_15_10_2_1_F12.fq.gz
SAMN34331267	E1504_15_10_2_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_15_10_2_1_G01.fq.gz
SAMN34331629	E1504_15_10_2_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_15_10_2_1_G02.fq.gz
SAMN34331630	E1504_15_10_2_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_15_10_2_1_G03.fq.gz
SAMN34331631	E1504_15_10_2_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_15_10_2_1_G04.fq.gz
SAMN34331632	E1504_15_10_2_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_15_10_2_1_G05.fq.gz
SAMN34331633	E1504_15_10_2_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_15_10_2_1_G06.fq.gz
SAMN34331634	E1504_15_10_2_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_15_10_2_1_G07.fq.gz
SAMN34331635	E1504_15_10_2_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_15_10_2_1_G08.fq.gz
SAMN34331636	E1504_15_10_2_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_15_10_2_1_G09.fq.gz
SAMN34331637	E1504_15_10_2_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_15_10_2_1_G10.fq.gz
SAMN34331638	E1504_15_10_2_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_15_10_2_1_G11.fq.gz
SAMN34331267	E1504_15_10_2_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_15_10_2_1_G12.fq.gz
SAMN34331278	E1504_15_10_2_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_15_10_2_1_H01.fq.gz
SAMN34331639	E1504_15_10_2_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_15_10_2_1_H02.fq.gz
SAMN34331640	E1504_15_10_2_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_15_10_2_1_H03.fq.gz
SAMN34331641	E1504_15_10_2_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_15_10_2_1_H04.fq.gz
SAMN34331642	E1504_15_10_2_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_15_10_2_1_H05.fq.gz
SAMN34331643	E1504_15_10_2_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_15_10_2_1_H06.fq.gz
SAMN34331644	E1504_15_10_2_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_15_10_2_1_H07.fq.gz
SAMN34331645	E1504_15_10_2_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_15_10_2_1_H08.fq.gz
SAMN34331646	E1504_15_10_2_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_15_10_2_1_H09.fq.gz
SAMN34331647	E1504_15_10_2_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_15_10_2_1_H10.fq.gz
SAMN34331648	E1504_15_10_2_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_15_10_2_1_H11.fq.gz
SAMN34331278	E1504_15_10_2_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_15_10_2_1_H12.fq.gz
SAMN34331245	E1504_16_10_2_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_1_E1504_01_100_1_1_A01_ACAAGCTA_E1504_16_10_2_2_A01.fq.gz
SAMN34331649	E1504_16_10_2_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_2_E1504_01_100_1_1_A02_AAACATCG_E1504_16_10_2_2_A02.fq.gz
SAMN34331650	E1504_16_10_2_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_3_E1504_01_100_1_1_A03_ACATTGGC_E1504_16_10_2_2_A03.fq.gz
SAMN34331651	E1504_16_10_2_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_4_E1504_01_100_1_1_A04_ACCACTGT_E1504_16_10_2_2_A04.fq.gz
SAMN34331652	E1504_16_10_2_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_5_E1504_01_100_1_1_A05_AACGTGAT_E1504_16_10_2_2_A05.fq.gz
SAMN34331653	E1504_16_10_2_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_6_E1504_01_100_1_1_A06_CGCTGATC_E1504_16_10_2_2_A06.fq.gz
SAMN34331654	E1504_16_10_2_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_7_E1504_01_100_1_1_A07_CAGATCTG_E1504_16_10_2_2_A07.fq.gz
SAMN34331655	E1504_16_10_2_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_8_E1504_01_100_1_1_A08_ATGCCTAA_E1504_16_10_2_2_A08.fq.gz
SAMN34331656	E1504_16_10_2_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_9_E1504_01_100_1_1_A09_CTGTAGCC_E1504_16_10_2_2_A09.fq.gz
SAMN34331657	E1504_16_10_2_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_10_E1504_01_100_1_1_A10_AGTACAAG_E1504_16_10_2_2_A10.fq.gz
SAMN34331658	E1504_16_10_2_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_11_E1504_01_100_1_1_A11_CATCAAGT_E1504_16_10_2_2_A11.fq.gz
SAMN34331245	E1504_16_10_2_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_12_E1504_01_100_1_1_A12_AGTGGTCA_E1504_16_10_2_2_A12.fq.gz
SAMN34331256	E1504_16_10_2_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_13_E1504_01_100_1_1_B01_AACAACCA_E1504_16_10_2_2_B01.fq.gz
SAMN34331659	E1504_16_10_2_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_14_E1504_01_100_1_1_B02_AACCGAGA_E1504_16_10_2_2_B02.fq.gz
SAMN34331660	E1504_16_10_2_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_15_E1504_01_100_1_1_B03_AACGCTTA_E1504_16_10_2_2_B03.fq.gz
SAMN34331661	E1504_16_10_2_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_16_E1504_01_100_1_1_B04_AAGACGGA_E1504_16_10_2_2_B04.fq.gz
SAMN34331662	E1504_16_10_2_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_17_E1504_01_100_1_1_B05_AAGGTACA_E1504_16_10_2_2_B05.fq.gz
SAMN34331663	E1504_16_10_2_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_18_E1504_01_100_1_1_B06_ACACAGAA_E1504_16_10_2_2_B06.fq.gz
SAMN34331664	E1504_16_10_2_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_19_E1504_01_100_1_1_B07_ACAGCAGA_E1504_16_10_2_2_B07.fq.gz
SAMN34331665	E1504_16_10_2_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_20_E1504_01_100_1_1_B08_ACCTCCAA_E1504_16_10_2_2_B08.fq.gz
SAMN34331666	E1504_16_10_2_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_21_E1504_01_100_1_1_B09_ACGCTCGA_E1504_16_10_2_2_B09.fq.gz
SAMN34331667	E1504_16_10_2_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_22_E1504_01_100_1_1_B10_ACGTATCA_E1504_16_10_2_2_B10.fq.gz
SAMN34331668	E1504_16_10_2_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_23_E1504_01_100_1_1_B11_ACTATGCA_E1504_16_10_2_2_B11.fq.gz
SAMN34331256	E1504_16_10_2_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_24_E1504_01_100_1_1_B12_AGAGTCAA_E1504_16_10_2_2_B12.fq.gz
SAMN34331267	E1504_16_10_2_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_25_E1504_01_100_1_1_C01_AGATCGCA_E1504_16_10_2_2_C01.fq.gz
SAMN34331669	E1504_16_10_2_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_26_E1504_01_100_1_1_C02_AGCAGGAA_E1504_16_10_2_2_C02.fq.gz
SAMN34331670	E1504_16_10_2_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_27_E1504_01_100_1_1_C03_AGTCACTA_E1504_16_10_2_2_C03.fq.gz
SAMN34331671	E1504_16_10_2_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_28_E1504_01_100_1_1_C04_ATCCTGTA_E1504_16_10_2_2_C04.fq.gz
SAMN34331672	E1504_16_10_2_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_29_E1504_01_100_1_1_C05_ATTGAGGA_E1504_16_10_2_2_C05.fq.gz
SAMN34331673	E1504_16_10_2_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_30_E1504_01_100_1_1_C06_CAACCACA_E1504_16_10_2_2_C06.fq.gz
SAMN34331674	E1504_16_10_2_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_31_E1504_01_100_1_1_C07_CAAGACTA_E1504_16_10_2_2_C07.fq.gz
SAMN34331675	E1504_16_10_2_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_32_E1504_01_100_1_1_C08_CAATGGAA_E1504_16_10_2_2_C08.fq.gz
SAMN34331676	E1504_16_10_2_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_33_E1504_01_100_1_1_C09_CACTTCGA_E1504_16_10_2_2_C09.fq.gz
SAMN34331677	E1504_16_10_2_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_34_E1504_01_100_1_1_C10_CAGCGTTA_E1504_16_10_2_2_C10.fq.gz
SAMN34331678	E1504_16_10_2_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_35_E1504_01_100_1_1_C11_CATACCAA_E1504_16_10_2_2_C11.fq.gz
SAMN34331267	E1504_16_10_2_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_36_E1504_01_100_1_1_C12_CCAGTTCA_E1504_16_10_2_2_C12.fq.gz
SAMN34331278	E1504_16_10_2_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_37_E1504_01_100_1_1_D01_CCGAAGTA_E1504_16_10_2_2_D01.fq.gz
SAMN34331679	E1504_16_10_2_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_38_E1504_01_100_1_1_D02_CCGTGAGA_E1504_16_10_2_2_D02.fq.gz
SAMN34331680	E1504_16_10_2_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_39_E1504_01_100_1_1_D03_CCTCCTGA_E1504_16_10_2_2_D03.fq.gz
SAMN34331681	E1504_16_10_2_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_40_E1504_01_100_1_1_D04_CGAACTTA_E1504_16_10_2_2_D04.fq.gz
SAMN34331682	E1504_16_10_2_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_41_E1504_01_100_1_1_D05_CGACTGGA_E1504_16_10_2_2_D05.fq.gz
SAMN34331683	E1504_16_10_2_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_16_10_2_2_D06.fq.gz
SAMN34331684	E1504_16_10_2_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_16_10_2_2_D07.fq.gz
SAMN34331685	E1504_16_10_2_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_16_10_2_2_D08.fq.gz
SAMN34331686	E1504_16_10_2_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_16_10_2_2_D09.fq.gz
SAMN34331687	E1504_16_10_2_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_16_10_2_2_D10.fq.gz
SAMN34331688	E1504_16_10_2_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_16_10_2_2_D11.fq.gz
SAMN34331278	E1504_16_10_2_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_16_10_2_2_D12.fq.gz
SAMN34331245	E1504_16_10_2_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_16_10_2_2_E01.fq.gz
SAMN34331689	E1504_16_10_2_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_16_10_2_2_E02.fq.gz
SAMN34331690	E1504_16_10_2_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_16_10_2_2_E03.fq.gz
SAMN34331691	E1504_16_10_2_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_16_10_2_2_E04.fq.gz
SAMN34331692	E1504_16_10_2_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_16_10_2_2_E05.fq.gz
SAMN34331693	E1504_16_10_2_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_16_10_2_2_E06.fq.gz
SAMN34331694	E1504_16_10_2_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_16_10_2_2_E07.fq.gz
SAMN34331695	E1504_16_10_2_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_16_10_2_2_E08.fq.gz
SAMN34331696	E1504_16_10_2_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_16_10_2_2_E09.fq.gz
SAMN34331697	E1504_16_10_2_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_16_10_2_2_E10.fq.gz
SAMN34331698	E1504_16_10_2_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_16_10_2_2_E11.fq.gz
SAMN34331245	E1504_16_10_2_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_16_10_2_2_E12.fq.gz
SAMN34331256	E1504_16_10_2_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_16_10_2_2_F01.fq.gz
SAMN34331699	E1504_16_10_2_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_16_10_2_2_F02.fq.gz
SAMN34331700	E1504_16_10_2_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_16_10_2_2_F03.fq.gz
SAMN34331701	E1504_16_10_2_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_16_10_2_2_F04.fq.gz
SAMN34331702	E1504_16_10_2_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_16_10_2_2_F05.fq.gz
SAMN34331703	E1504_16_10_2_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_16_10_2_2_F06.fq.gz
SAMN34331704	E1504_16_10_2_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_16_10_2_2_F07.fq.gz
SAMN34331705	E1504_16_10_2_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_16_10_2_2_F08.fq.gz
SAMN34331706	E1504_16_10_2_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_16_10_2_2_F09.fq.gz
SAMN34331707	E1504_16_10_2_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_16_10_2_2_F10.fq.gz
SAMN34331708	E1504_16_10_2_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_16_10_2_2_F11.fq.gz
SAMN34331256	E1504_16_10_2_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_16_10_2_2_F12.fq.gz
SAMN34331267	E1504_16_10_2_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_16_10_2_2_G01.fq.gz
SAMN34331709	E1504_16_10_2_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_16_10_2_2_G02.fq.gz
SAMN34331710	E1504_16_10_2_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_16_10_2_2_G03.fq.gz
SAMN34331711	E1504_16_10_2_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_16_10_2_2_G04.fq.gz
SAMN34331712	E1504_16_10_2_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_16_10_2_2_G05.fq.gz
SAMN34331713	E1504_16_10_2_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_16_10_2_2_G06.fq.gz
SAMN34331714	E1504_16_10_2_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_16_10_2_2_G07.fq.gz
SAMN34331715	E1504_16_10_2_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_16_10_2_2_G08.fq.gz
SAMN34331716	E1504_16_10_2_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_16_10_2_2_G09.fq.gz
SAMN34331717	E1504_16_10_2_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_16_10_2_2_G10.fq.gz
SAMN34331718	E1504_16_10_2_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_16_10_2_2_G11.fq.gz
SAMN34331267	E1504_16_10_2_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_16_10_2_2_G12.fq.gz
SAMN34331278	E1504_16_10_2_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_16_10_2_2_H01.fq.gz
SAMN34331719	E1504_16_10_2_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_16_10_2_2_H02.fq.gz
SAMN34331720	E1504_16_10_2_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_16_10_2_2_H03.fq.gz
SAMN34331721	E1504_16_10_2_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_16_10_2_2_H04.fq.gz
SAMN34331722	E1504_16_10_2_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_16_10_2_2_H05.fq.gz
SAMN34331723	E1504_16_10_2_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_16_10_2_2_H06.fq.gz
SAMN34331724	E1504_16_10_2_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_16_10_2_2_H07.fq.gz
SAMN34331725	E1504_16_10_2_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_16_10_2_2_H08.fq.gz
SAMN34331726	E1504_16_10_2_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_16_10_2_2_H09.fq.gz
SAMN34331727	E1504_16_10_2_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_16_10_2_2_H10.fq.gz
SAMN34331728	E1504_16_10_2_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_16_10_2_2_H11.fq.gz
SAMN34331278	E1504_16_10_2_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_16_10_2_2_H12.fq.gz
SAMN34331245	E1504_17_10_3_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_1_E1504_01_100_1_1_A01_ACAAGCTA_E1504_17_10_3_1_A01.fq.gz
SAMN34331569	E1504_17_10_3_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_2_E1504_01_100_1_1_A02_AAACATCG_E1504_17_10_3_1_A02.fq.gz
SAMN34331570	E1504_17_10_3_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_3_E1504_01_100_1_1_A03_ACATTGGC_E1504_17_10_3_1_A03.fq.gz
SAMN34331571	E1504_17_10_3_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_4_E1504_01_100_1_1_A04_ACCACTGT_E1504_17_10_3_1_A04.fq.gz
SAMN34331572	E1504_17_10_3_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_5_E1504_01_100_1_1_A05_AACGTGAT_E1504_17_10_3_1_A05.fq.gz
SAMN34331573	E1504_17_10_3_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_6_E1504_01_100_1_1_A06_CGCTGATC_E1504_17_10_3_1_A06.fq.gz
SAMN34331574	E1504_17_10_3_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_7_E1504_01_100_1_1_A07_CAGATCTG_E1504_17_10_3_1_A07.fq.gz
SAMN34331575	E1504_17_10_3_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_8_E1504_01_100_1_1_A08_ATGCCTAA_E1504_17_10_3_1_A08.fq.gz
SAMN34331576	E1504_17_10_3_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_9_E1504_01_100_1_1_A09_CTGTAGCC_E1504_17_10_3_1_A09.fq.gz
SAMN34331577	E1504_17_10_3_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_10_E1504_01_100_1_1_A10_AGTACAAG_E1504_17_10_3_1_A10.fq.gz
SAMN34331578	E1504_17_10_3_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_11_E1504_01_100_1_1_A11_CATCAAGT_E1504_17_10_3_1_A11.fq.gz
SAMN34331245	E1504_17_10_3_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_12_E1504_01_100_1_1_A12_AGTGGTCA_E1504_17_10_3_1_A12.fq.gz
SAMN34331256	E1504_17_10_3_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_13_E1504_01_100_1_1_B01_AACAACCA_E1504_17_10_3_1_B01.fq.gz
SAMN34331579	E1504_17_10_3_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_14_E1504_01_100_1_1_B02_AACCGAGA_E1504_17_10_3_1_B02.fq.gz
SAMN34331580	E1504_17_10_3_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_15_E1504_01_100_1_1_B03_AACGCTTA_E1504_17_10_3_1_B03.fq.gz
SAMN34331581	E1504_17_10_3_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_16_E1504_01_100_1_1_B04_AAGACGGA_E1504_17_10_3_1_B04.fq.gz
SAMN34331582	E1504_17_10_3_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_17_E1504_01_100_1_1_B05_AAGGTACA_E1504_17_10_3_1_B05.fq.gz
SAMN34331583	E1504_17_10_3_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_18_E1504_01_100_1_1_B06_ACACAGAA_E1504_17_10_3_1_B06.fq.gz
SAMN34331584	E1504_17_10_3_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_19_E1504_01_100_1_1_B07_ACAGCAGA_E1504_17_10_3_1_B07.fq.gz
SAMN34331585	E1504_17_10_3_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_20_E1504_01_100_1_1_B08_ACCTCCAA_E1504_17_10_3_1_B08.fq.gz
SAMN34331586	E1504_17_10_3_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_21_E1504_01_100_1_1_B09_ACGCTCGA_E1504_17_10_3_1_B09.fq.gz
SAMN34331587	E1504_17_10_3_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_22_E1504_01_100_1_1_B10_ACGTATCA_E1504_17_10_3_1_B10.fq.gz
SAMN34331588	E1504_17_10_3_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_23_E1504_01_100_1_1_B11_ACTATGCA_E1504_17_10_3_1_B11.fq.gz
SAMN34331256	E1504_17_10_3_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_24_E1504_01_100_1_1_B12_AGAGTCAA_E1504_17_10_3_1_B12.fq.gz
SAMN34331267	E1504_17_10_3_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_25_E1504_01_100_1_1_C01_AGATCGCA_E1504_17_10_3_1_C01.fq.gz
SAMN34331589	E1504_17_10_3_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_26_E1504_01_100_1_1_C02_AGCAGGAA_E1504_17_10_3_1_C02.fq.gz
SAMN34331590	E1504_17_10_3_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_27_E1504_01_100_1_1_C03_AGTCACTA_E1504_17_10_3_1_C03.fq.gz
SAMN34331591	E1504_17_10_3_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_28_E1504_01_100_1_1_C04_ATCCTGTA_E1504_17_10_3_1_C04.fq.gz
SAMN34331592	E1504_17_10_3_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_29_E1504_01_100_1_1_C05_ATTGAGGA_E1504_17_10_3_1_C05.fq.gz
SAMN34331593	E1504_17_10_3_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_30_E1504_01_100_1_1_C06_CAACCACA_E1504_17_10_3_1_C06.fq.gz
SAMN34331594	E1504_17_10_3_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_31_E1504_01_100_1_1_C07_CAAGACTA_E1504_17_10_3_1_C07.fq.gz
SAMN34331595	E1504_17_10_3_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_32_E1504_01_100_1_1_C08_CAATGGAA_E1504_17_10_3_1_C08.fq.gz
SAMN34331596	E1504_17_10_3_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_33_E1504_01_100_1_1_C09_CACTTCGA_E1504_17_10_3_1_C09.fq.gz
SAMN34331597	E1504_17_10_3_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_34_E1504_01_100_1_1_C10_CAGCGTTA_E1504_17_10_3_1_C10.fq.gz
SAMN34331598	E1504_17_10_3_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_35_E1504_01_100_1_1_C11_CATACCAA_E1504_17_10_3_1_C11.fq.gz
SAMN34331267	E1504_17_10_3_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_36_E1504_01_100_1_1_C12_CCAGTTCA_E1504_17_10_3_1_C12.fq.gz
SAMN34331278	E1504_17_10_3_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_37_E1504_01_100_1_1_D01_CCGAAGTA_E1504_17_10_3_1_D01.fq.gz
SAMN34331599	E1504_17_10_3_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_38_E1504_01_100_1_1_D02_CCGTGAGA_E1504_17_10_3_1_D02.fq.gz
SAMN34331600	E1504_17_10_3_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_39_E1504_01_100_1_1_D03_CCTCCTGA_E1504_17_10_3_1_D03.fq.gz
SAMN34331601	E1504_17_10_3_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_40_E1504_01_100_1_1_D04_CGAACTTA_E1504_17_10_3_1_D04.fq.gz
SAMN34331602	E1504_17_10_3_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_41_E1504_01_100_1_1_D05_CGACTGGA_E1504_17_10_3_1_D05.fq.gz
SAMN34331603	E1504_17_10_3_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_17_10_3_1_D06.fq.gz
SAMN34331604	E1504_17_10_3_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_17_10_3_1_D07.fq.gz
SAMN34331605	E1504_17_10_3_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_17_10_3_1_D08.fq.gz
SAMN34331606	E1504_17_10_3_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_17_10_3_1_D09.fq.gz
SAMN34331607	E1504_17_10_3_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_17_10_3_1_D10.fq.gz
SAMN34331608	E1504_17_10_3_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_17_10_3_1_D11.fq.gz
SAMN34331278	E1504_17_10_3_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_17_10_3_1_D12.fq.gz
SAMN34331245	E1504_17_10_3_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_17_10_3_1_E01.fq.gz
SAMN34331609	E1504_17_10_3_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_17_10_3_1_E02.fq.gz
SAMN34331610	E1504_17_10_3_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_17_10_3_1_E03.fq.gz
SAMN34331611	E1504_17_10_3_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_17_10_3_1_E04.fq.gz
SAMN34331612	E1504_17_10_3_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_17_10_3_1_E05.fq.gz
SAMN34331613	E1504_17_10_3_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_17_10_3_1_E06.fq.gz
SAMN34331614	E1504_17_10_3_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_17_10_3_1_E07.fq.gz
SAMN34331615	E1504_17_10_3_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_17_10_3_1_E08.fq.gz
SAMN34331616	E1504_17_10_3_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_17_10_3_1_E09.fq.gz
SAMN34331617	E1504_17_10_3_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_17_10_3_1_E10.fq.gz
SAMN34331618	E1504_17_10_3_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_17_10_3_1_E11.fq.gz
SAMN34331245	E1504_17_10_3_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_17_10_3_1_E12.fq.gz
SAMN34331256	E1504_17_10_3_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_17_10_3_1_F01.fq.gz
SAMN34331619	E1504_17_10_3_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_17_10_3_1_F02.fq.gz
SAMN34331620	E1504_17_10_3_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_17_10_3_1_F03.fq.gz
SAMN34331621	E1504_17_10_3_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_17_10_3_1_F04.fq.gz
SAMN34331622	E1504_17_10_3_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_17_10_3_1_F05.fq.gz
SAMN34331623	E1504_17_10_3_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_17_10_3_1_F06.fq.gz
SAMN34331624	E1504_17_10_3_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_17_10_3_1_F07.fq.gz
SAMN34331625	E1504_17_10_3_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_17_10_3_1_F08.fq.gz
SAMN34331626	E1504_17_10_3_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_17_10_3_1_F09.fq.gz
SAMN34331627	E1504_17_10_3_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_17_10_3_1_F10.fq.gz
SAMN34331628	E1504_17_10_3_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_17_10_3_1_F11.fq.gz
SAMN34331256	E1504_17_10_3_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_17_10_3_1_F12.fq.gz
SAMN34331267	E1504_17_10_3_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_17_10_3_1_G01.fq.gz
SAMN34331629	E1504_17_10_3_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_17_10_3_1_G02.fq.gz
SAMN34331630	E1504_17_10_3_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_17_10_3_1_G03.fq.gz
SAMN34331631	E1504_17_10_3_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_17_10_3_1_G04.fq.gz
SAMN34331632	E1504_17_10_3_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_17_10_3_1_G05.fq.gz
SAMN34331633	E1504_17_10_3_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_17_10_3_1_G06.fq.gz
SAMN34331634	E1504_17_10_3_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_17_10_3_1_G07.fq.gz
SAMN34331635	E1504_17_10_3_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_17_10_3_1_G08.fq.gz
SAMN34331636	E1504_17_10_3_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_17_10_3_1_G09.fq.gz
SAMN34331637	E1504_17_10_3_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_17_10_3_1_G10.fq.gz
SAMN34331638	E1504_17_10_3_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_17_10_3_1_G11.fq.gz
SAMN34331267	E1504_17_10_3_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_17_10_3_1_G12.fq.gz
SAMN34331278	E1504_17_10_3_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_17_10_3_1_H01.fq.gz
SAMN34331639	E1504_17_10_3_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_17_10_3_1_H02.fq.gz
SAMN34331640	E1504_17_10_3_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_17_10_3_1_H03.fq.gz
SAMN34331641	E1504_17_10_3_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_17_10_3_1_H04.fq.gz
SAMN34331642	E1504_17_10_3_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_17_10_3_1_H05.fq.gz
SAMN34331643	E1504_17_10_3_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_17_10_3_1_H06.fq.gz
SAMN34331644	E1504_17_10_3_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_17_10_3_1_H07.fq.gz
SAMN34331645	E1504_17_10_3_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_17_10_3_1_H08.fq.gz
SAMN34331646	E1504_17_10_3_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_17_10_3_1_H09.fq.gz
SAMN34331647	E1504_17_10_3_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_17_10_3_1_H10.fq.gz
SAMN34331648	E1504_17_10_3_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_17_10_3_1_H11.fq.gz
SAMN34331278	E1504_17_10_3_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_17_10_3_1_H12.fq.gz
SAMN34331245	E1504_18_10_3_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_1_E1504_01_100_1_1_A01_ACAAGCTA_E1504_18_10_3_2_A01.fq.gz
SAMN34331649	E1504_18_10_3_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_2_E1504_01_100_1_1_A02_AAACATCG_E1504_18_10_3_2_A02.fq.gz
SAMN34331650	E1504_18_10_3_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_3_E1504_01_100_1_1_A03_ACATTGGC_E1504_18_10_3_2_A03.fq.gz
SAMN34331651	E1504_18_10_3_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_4_E1504_01_100_1_1_A04_ACCACTGT_E1504_18_10_3_2_A04.fq.gz
SAMN34331652	E1504_18_10_3_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_5_E1504_01_100_1_1_A05_AACGTGAT_E1504_18_10_3_2_A05.fq.gz
SAMN34331653	E1504_18_10_3_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_6_E1504_01_100_1_1_A06_CGCTGATC_E1504_18_10_3_2_A06.fq.gz
SAMN34331654	E1504_18_10_3_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_7_E1504_01_100_1_1_A07_CAGATCTG_E1504_18_10_3_2_A07.fq.gz
SAMN34331655	E1504_18_10_3_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_8_E1504_01_100_1_1_A08_ATGCCTAA_E1504_18_10_3_2_A08.fq.gz
SAMN34331656	E1504_18_10_3_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_9_E1504_01_100_1_1_A09_CTGTAGCC_E1504_18_10_3_2_A09.fq.gz
SAMN34331657	E1504_18_10_3_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_10_E1504_01_100_1_1_A10_AGTACAAG_E1504_18_10_3_2_A10.fq.gz
SAMN34331658	E1504_18_10_3_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_11_E1504_01_100_1_1_A11_CATCAAGT_E1504_18_10_3_2_A11.fq.gz
SAMN34331245	E1504_18_10_3_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_12_E1504_01_100_1_1_A12_AGTGGTCA_E1504_18_10_3_2_A12.fq.gz
SAMN34331256	E1504_18_10_3_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_13_E1504_01_100_1_1_B01_AACAACCA_E1504_18_10_3_2_B01.fq.gz
SAMN34331659	E1504_18_10_3_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_14_E1504_01_100_1_1_B02_AACCGAGA_E1504_18_10_3_2_B02.fq.gz
SAMN34331660	E1504_18_10_3_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_15_E1504_01_100_1_1_B03_AACGCTTA_E1504_18_10_3_2_B03.fq.gz
SAMN34331661	E1504_18_10_3_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_16_E1504_01_100_1_1_B04_AAGACGGA_E1504_18_10_3_2_B04.fq.gz
SAMN34331662	E1504_18_10_3_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_17_E1504_01_100_1_1_B05_AAGGTACA_E1504_18_10_3_2_B05.fq.gz
SAMN34331663	E1504_18_10_3_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_18_E1504_01_100_1_1_B06_ACACAGAA_E1504_18_10_3_2_B06.fq.gz
SAMN34331664	E1504_18_10_3_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_19_E1504_01_100_1_1_B07_ACAGCAGA_E1504_18_10_3_2_B07.fq.gz
SAMN34331665	E1504_18_10_3_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_20_E1504_01_100_1_1_B08_ACCTCCAA_E1504_18_10_3_2_B08.fq.gz
SAMN34331666	E1504_18_10_3_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_21_E1504_01_100_1_1_B09_ACGCTCGA_E1504_18_10_3_2_B09.fq.gz
SAMN34331667	E1504_18_10_3_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_22_E1504_01_100_1_1_B10_ACGTATCA_E1504_18_10_3_2_B10.fq.gz
SAMN34331668	E1504_18_10_3_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_23_E1504_01_100_1_1_B11_ACTATGCA_E1504_18_10_3_2_B11.fq.gz
SAMN34331256	E1504_18_10_3_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_24_E1504_01_100_1_1_B12_AGAGTCAA_E1504_18_10_3_2_B12.fq.gz
SAMN34331267	E1504_18_10_3_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_25_E1504_01_100_1_1_C01_AGATCGCA_E1504_18_10_3_2_C01.fq.gz
SAMN34331669	E1504_18_10_3_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_26_E1504_01_100_1_1_C02_AGCAGGAA_E1504_18_10_3_2_C02.fq.gz
SAMN34331670	E1504_18_10_3_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_27_E1504_01_100_1_1_C03_AGTCACTA_E1504_18_10_3_2_C03.fq.gz
SAMN34331671	E1504_18_10_3_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_28_E1504_01_100_1_1_C04_ATCCTGTA_E1504_18_10_3_2_C04.fq.gz
SAMN34331672	E1504_18_10_3_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_29_E1504_01_100_1_1_C05_ATTGAGGA_E1504_18_10_3_2_C05.fq.gz
SAMN34331673	E1504_18_10_3_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_30_E1504_01_100_1_1_C06_CAACCACA_E1504_18_10_3_2_C06.fq.gz
SAMN34331674	E1504_18_10_3_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_31_E1504_01_100_1_1_C07_CAAGACTA_E1504_18_10_3_2_C07.fq.gz
SAMN34331675	E1504_18_10_3_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_32_E1504_01_100_1_1_C08_CAATGGAA_E1504_18_10_3_2_C08.fq.gz
SAMN34331676	E1504_18_10_3_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_33_E1504_01_100_1_1_C09_CACTTCGA_E1504_18_10_3_2_C09.fq.gz
SAMN34331677	E1504_18_10_3_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_34_E1504_01_100_1_1_C10_CAGCGTTA_E1504_18_10_3_2_C10.fq.gz
SAMN34331678	E1504_18_10_3_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_35_E1504_01_100_1_1_C11_CATACCAA_E1504_18_10_3_2_C11.fq.gz
SAMN34331267	E1504_18_10_3_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_36_E1504_01_100_1_1_C12_CCAGTTCA_E1504_18_10_3_2_C12.fq.gz
SAMN34331278	E1504_18_10_3_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_37_E1504_01_100_1_1_D01_CCGAAGTA_E1504_18_10_3_2_D01.fq.gz
SAMN34331679	E1504_18_10_3_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_38_E1504_01_100_1_1_D02_CCGTGAGA_E1504_18_10_3_2_D02.fq.gz
SAMN34331680	E1504_18_10_3_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_39_E1504_01_100_1_1_D03_CCTCCTGA_E1504_18_10_3_2_D03.fq.gz
SAMN34331681	E1504_18_10_3_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_40_E1504_01_100_1_1_D04_CGAACTTA_E1504_18_10_3_2_D04.fq.gz
SAMN34331682	E1504_18_10_3_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_41_E1504_01_100_1_1_D05_CGACTGGA_E1504_18_10_3_2_D05.fq.gz
SAMN34331683	E1504_18_10_3_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_42_E1504_01_100_1_1_D06_CGCATACA_E1504_18_10_3_2_D06.fq.gz
SAMN34331684	E1504_18_10_3_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_43_E1504_01_100_1_1_D07_CTCAATGA_E1504_18_10_3_2_D07.fq.gz
SAMN34331685	E1504_18_10_3_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_44_E1504_01_100_1_1_D08_CTGAGCCA_E1504_18_10_3_2_D08.fq.gz
SAMN34331686	E1504_18_10_3_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_45_E1504_01_100_1_1_D09_CTGGCATA_E1504_18_10_3_2_D09.fq.gz
SAMN34331687	E1504_18_10_3_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_46_E1504_01_100_1_1_D10_GAATCTGA_E1504_18_10_3_2_D10.fq.gz
SAMN34331688	E1504_18_10_3_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_47_E1504_01_100_1_1_D11_GACTAGTA_E1504_18_10_3_2_D11.fq.gz
SAMN34331278	E1504_18_10_3_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_48_E1504_01_100_1_1_D12_GAGCTGAA_E1504_18_10_3_2_D12.fq.gz
SAMN34331245	E1504_18_10_3_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_49_E1504_01_100_1_1_E01_GATAGACA_E1504_18_10_3_2_E01.fq.gz
SAMN34331689	E1504_18_10_3_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_50_E1504_01_100_1_1_E02_GCCACATA_E1504_18_10_3_2_E02.fq.gz
SAMN34331690	E1504_18_10_3_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_51_E1504_01_100_1_1_E03_GCGAGTAA_E1504_18_10_3_2_E03.fq.gz
SAMN34331691	E1504_18_10_3_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_52_E1504_01_100_1_1_E04_GCTAACGA_E1504_18_10_3_2_E04.fq.gz
SAMN34331692	E1504_18_10_3_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_53_E1504_01_100_1_1_E05_GCTCGGTA_E1504_18_10_3_2_E05.fq.gz
SAMN34331693	E1504_18_10_3_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_54_E1504_01_100_1_1_E06_GGAGAACA_E1504_18_10_3_2_E06.fq.gz
SAMN34331694	E1504_18_10_3_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_55_E1504_01_100_1_1_E07_GGTGCGAA_E1504_18_10_3_2_E07.fq.gz
SAMN34331695	E1504_18_10_3_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_56_E1504_01_100_1_1_E08_GTACGCAA_E1504_18_10_3_2_E08.fq.gz
SAMN34331696	E1504_18_10_3_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_57_E1504_01_100_1_1_E09_GTCGTAGA_E1504_18_10_3_2_E09.fq.gz
SAMN34331697	E1504_18_10_3_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_58_E1504_01_100_1_1_E10_GTCTGTCA_E1504_18_10_3_2_E10.fq.gz
SAMN34331698	E1504_18_10_3_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_59_E1504_01_100_1_1_E11_GTGTTCTA_E1504_18_10_3_2_E11.fq.gz
SAMN34331245	E1504_18_10_3_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_60_E1504_01_100_1_1_E12_TAGGATGA_E1504_18_10_3_2_E12.fq.gz
SAMN34331256	E1504_18_10_3_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_61_E1504_01_100_1_1_F01_TATCAGCA_E1504_18_10_3_2_F01.fq.gz
SAMN34331699	E1504_18_10_3_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_62_E1504_01_100_1_1_F02_TCCGTCTA_E1504_18_10_3_2_F02.fq.gz
SAMN34331700	E1504_18_10_3_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_63_E1504_01_100_1_1_F03_TCTTCACA_E1504_18_10_3_2_F03.fq.gz
SAMN34331701	E1504_18_10_3_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_64_E1504_01_100_1_1_F04_TGAAGAGA_E1504_18_10_3_2_F04.fq.gz
SAMN34331702	E1504_18_10_3_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_65_E1504_01_100_1_1_F05_TGGAACAA_E1504_18_10_3_2_F05.fq.gz
SAMN34331703	E1504_18_10_3_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_66_E1504_01_100_1_1_F06_TGGCTTCA_E1504_18_10_3_2_F06.fq.gz
SAMN34331704	E1504_18_10_3_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_67_E1504_01_100_1_1_F07_TGGTGGTA_E1504_18_10_3_2_F07.fq.gz
SAMN34331705	E1504_18_10_3_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_68_E1504_01_100_1_1_F08_TTCACGCA_E1504_18_10_3_2_F08.fq.gz
SAMN34331706	E1504_18_10_3_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_69_E1504_01_100_1_1_F09_AACTCACC_E1504_18_10_3_2_F09.fq.gz
SAMN34331707	E1504_18_10_3_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_70_E1504_01_100_1_1_F10_AAGAGATC_E1504_18_10_3_2_F10.fq.gz
SAMN34331708	E1504_18_10_3_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_71_E1504_01_100_1_1_F11_AAGGACAC_E1504_18_10_3_2_F11.fq.gz
SAMN34331256	E1504_18_10_3_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_72_E1504_01_100_1_1_F12_AATCCGTC_E1504_18_10_3_2_F12.fq.gz
SAMN34331267	E1504_18_10_3_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_73_E1504_01_100_1_1_G01_AATGTTGC_E1504_18_10_3_2_G01.fq.gz
SAMN34331709	E1504_18_10_3_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_74_E1504_01_100_1_1_G02_ACACGACC_E1504_18_10_3_2_G02.fq.gz
SAMN34331710	E1504_18_10_3_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_75_E1504_01_100_1_1_G03_ACAGATTC_E1504_18_10_3_2_G03.fq.gz
SAMN34331711	E1504_18_10_3_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_76_E1504_01_100_1_1_G04_AGATGTAC_E1504_18_10_3_2_G04.fq.gz
SAMN34331712	E1504_18_10_3_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_77_E1504_01_100_1_1_G05_AGCACCTC_E1504_18_10_3_2_G05.fq.gz
SAMN34331713	E1504_18_10_3_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_78_E1504_01_100_1_1_G06_AGCCATGC_E1504_18_10_3_2_G06.fq.gz
SAMN34331714	E1504_18_10_3_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_79_E1504_01_100_1_1_G07_AGGCTAAC_E1504_18_10_3_2_G07.fq.gz
SAMN34331715	E1504_18_10_3_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_80_E1504_01_100_1_1_G08_ATAGCGAC_E1504_18_10_3_2_G08.fq.gz
SAMN34331716	E1504_18_10_3_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_81_E1504_01_100_1_1_G09_ATCATTCC_E1504_18_10_3_2_G09.fq.gz
SAMN34331717	E1504_18_10_3_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_82_E1504_01_100_1_1_G10_ATTGGCTC_E1504_18_10_3_2_G10.fq.gz
SAMN34331718	E1504_18_10_3_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_83_E1504_01_100_1_1_G11_CAAGGAGC_E1504_18_10_3_2_G11.fq.gz
SAMN34331267	E1504_18_10_3_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_84_E1504_01_100_1_1_G12_CACCTTAC_E1504_18_10_3_2_G12.fq.gz
SAMN34331278	E1504_18_10_3_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_85_E1504_01_100_1_1_H01_CCATCCTC_E1504_18_10_3_2_H01.fq.gz
SAMN34331719	E1504_18_10_3_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_86_E1504_01_100_1_1_H02_CCGACAAC_E1504_18_10_3_2_H02.fq.gz
SAMN34331720	E1504_18_10_3_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_87_E1504_01_100_1_1_H03_CCTAATCC_E1504_18_10_3_2_H03.fq.gz
SAMN34331721	E1504_18_10_3_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_88_E1504_01_100_1_1_H04_CCTCTATC_E1504_18_10_3_2_H04.fq.gz
SAMN34331722	E1504_18_10_3_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_89_E1504_01_100_1_1_H05_CGACACAC_E1504_18_10_3_2_H05.fq.gz
SAMN34331723	E1504_18_10_3_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_90_E1504_01_100_1_1_H06_CGGATTGC_E1504_18_10_3_2_H06.fq.gz
SAMN34331724	E1504_18_10_3_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_91_E1504_01_100_1_1_H07_CTAAGGTC_E1504_18_10_3_2_H07.fq.gz
SAMN34331725	E1504_18_10_3_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_92_E1504_01_100_1_1_H08_GAACAGGC_E1504_18_10_3_2_H08.fq.gz
SAMN34331726	E1504_18_10_3_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_93_E1504_01_100_1_1_H09_GACAGTGC_E1504_18_10_3_2_H09.fq.gz
SAMN34331727	E1504_18_10_3_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_94_E1504_01_100_1_1_H10_GAGTTAGC_E1504_18_10_3_2_H10.fq.gz
SAMN34331728	E1504_18_10_3_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_95_E1504_01_100_1_1_H11_GATGAATC_E1504_18_10_3_2_H11.fq.gz
SAMN34331278	E1504_18_10_3_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6475_96_E1504_01_100_1_1_H12_GCCAAGAC_E1504_18_10_3_2_H12.fq.gz
SAMN34331245	E177_01_100_1_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_100_1_1_R1.fq.gz
SAMN34331246	E177_01_100_1_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_100_1_1_R1.fq.gz
SAMN34331247	E177_01_100_1_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_100_1_1_R1.fq.gz
SAMN34331248	E177_01_100_1_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_100_1_1_R1.fq.gz
SAMN34331249	E177_01_100_1_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_100_1_1_R1.fq.gz
SAMN34331250	E177_01_100_1_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_100_1_1_R1.fq.gz
SAMN34331251	E177_01_100_1_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_100_1_1_R1.fq.gz
SAMN34331252	E177_01_100_1_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_100_1_1_R1.fq.gz
SAMN34331253	E177_01_100_1_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_100_1_1_R1.fq.gz
SAMN34331254	E177_01_100_1_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_100_1_1_R1.fq.gz
SAMN34331255	E177_01_100_1_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_100_1_1_R1.fq.gz
SAMN34331245	E177_01_100_1_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_100_1_1_R1.fq.gz
SAMN34331256	E177_01_100_1_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_100_1_1_R1.fq.gz
SAMN34331257	E177_01_100_1_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_100_1_1_R1.fq.gz
SAMN34331258	E177_01_100_1_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_100_1_1_R1.fq.gz
SAMN34331259	E177_01_100_1_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_100_1_1_R1.fq.gz
SAMN34331260	E177_01_100_1_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_100_1_1_R1.fq.gz
SAMN34331261	E177_01_100_1_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_100_1_1_R1.fq.gz
SAMN34331262	E177_01_100_1_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_100_1_1_R1.fq.gz
SAMN34331263	E177_01_100_1_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_100_1_1_R1.fq.gz
SAMN34331264	E177_01_100_1_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_100_1_1_R1.fq.gz
SAMN34331265	E177_01_100_1_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_100_1_1_R1.fq.gz
SAMN34331266	E177_01_100_1_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_100_1_1_R1.fq.gz
SAMN34331256	E177_01_100_1_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_100_1_1_R1.fq.gz
SAMN34331267	E177_01_100_1_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_100_1_1_R1.fq.gz
SAMN34331268	E177_01_100_1_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_100_1_1_R1.fq.gz
SAMN34331269	E177_01_100_1_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_100_1_1_R1.fq.gz
SAMN34331270	E177_01_100_1_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_100_1_1_R1.fq.gz
SAMN34331271	E177_01_100_1_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_100_1_1_R1.fq.gz
SAMN34331272	E177_01_100_1_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_100_1_1_R1.fq.gz
SAMN34331273	E177_01_100_1_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_100_1_1_R1.fq.gz
SAMN34331274	E177_01_100_1_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_100_1_1_R1.fq.gz
SAMN34331275	E177_01_100_1_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_100_1_1_R1.fq.gz
SAMN34331276	E177_01_100_1_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_100_1_1_R1.fq.gz
SAMN34331277	E177_01_100_1_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_100_1_1_R1.fq.gz
SAMN34331267	E177_01_100_1_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_100_1_1_R1.fq.gz
SAMN34331278	E177_01_100_1_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_100_1_1_R1.fq.gz
SAMN34331279	E177_01_100_1_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_100_1_1_R1.fq.gz
SAMN34331280	E177_01_100_1_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_100_1_1_R1.fq.gz
SAMN34331281	E177_01_100_1_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_100_1_1_R1.fq.gz
SAMN34331282	E177_01_100_1_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_100_1_1_R1.fq.gz
SAMN34331283	E177_01_100_1_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_100_1_1_R1.fq.gz
SAMN34331284	E177_01_100_1_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_100_1_1_R1.fq.gz
SAMN34331285	E177_01_100_1_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_100_1_1_R1.fq.gz
SAMN34331286	E177_01_100_1_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_100_1_1_R1.fq.gz
SAMN34331287	E177_01_100_1_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_100_1_1_R1.fq.gz
SAMN34331288	E177_01_100_1_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_100_1_1_R1.fq.gz
SAMN34331278	E177_01_100_1_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_100_1_1_R1.fq.gz
SAMN34331245	E177_01_100_1_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_100_1_1_R1.fq.gz
SAMN34331289	E177_01_100_1_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_100_1_1_R1.fq.gz
SAMN34331290	E177_01_100_1_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_100_1_1_R1.fq.gz
SAMN34331291	E177_01_100_1_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_100_1_1_R1.fq.gz
SAMN34331292	E177_01_100_1_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_100_1_1_R1.fq.gz
SAMN34331293	E177_01_100_1_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_100_1_1_R1.fq.gz
SAMN34331294	E177_01_100_1_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_100_1_1_R1.fq.gz
SAMN34331295	E177_01_100_1_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_100_1_1_R1.fq.gz
SAMN34331296	E177_01_100_1_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_100_1_1_R1.fq.gz
SAMN34331297	E177_01_100_1_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_100_1_1_R1.fq.gz
SAMN34331298	E177_01_100_1_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_100_1_1_R1.fq.gz
SAMN34331245	E177_01_100_1_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_100_1_1_R1.fq.gz
SAMN34331256	E177_01_100_1_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_100_1_1_R1.fq.gz
SAMN34331299	E177_01_100_1_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_100_1_1_R1.fq.gz
SAMN34331300	E177_01_100_1_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_100_1_1_R1.fq.gz
SAMN34331301	E177_01_100_1_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_100_1_1_R1.fq.gz
SAMN34331302	E177_01_100_1_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_100_1_1_R1.fq.gz
SAMN34331303	E177_01_100_1_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_100_1_1_R1.fq.gz
SAMN34331304	E177_01_100_1_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_100_1_1_R1.fq.gz
SAMN34331305	E177_01_100_1_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_100_1_1_R1.fq.gz
SAMN34331306	E177_01_100_1_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_100_1_1_R1.fq.gz
SAMN34331307	E177_01_100_1_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_100_1_1_R1.fq.gz
SAMN34331308	E177_01_100_1_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_100_1_1_R1.fq.gz
SAMN34331256	E177_01_100_1_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_100_1_1_R1.fq.gz
SAMN34331267	E177_01_100_1_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_100_1_1_R1.fq.gz
SAMN34331309	E177_01_100_1_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_100_1_1_R1.fq.gz
SAMN34331310	E177_01_100_1_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_100_1_1_R1.fq.gz
SAMN34331311	E177_01_100_1_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_100_1_1_R1.fq.gz
SAMN34331312	E177_01_100_1_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_100_1_1_R1.fq.gz
SAMN34331313	E177_01_100_1_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_100_1_1_R1.fq.gz
SAMN34331314	E177_01_100_1_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_100_1_1_R1.fq.gz
SAMN34331315	E177_01_100_1_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_100_1_1_R1.fq.gz
SAMN34331316	E177_01_100_1_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_100_1_1_R1.fq.gz
SAMN34331317	E177_01_100_1_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_100_1_1_R1.fq.gz
SAMN34331318	E177_01_100_1_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_100_1_1_R1.fq.gz
SAMN34331267	E177_01_100_1_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_100_1_1_R1.fq.gz
SAMN34331278	E177_01_100_1_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_100_1_1_R1.fq.gz
SAMN34331319	E177_01_100_1_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_100_1_1_R1.fq.gz
SAMN34331320	E177_01_100_1_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_100_1_1_R1.fq.gz
SAMN34331321	E177_01_100_1_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_100_1_1_R1.fq.gz
SAMN34331322	E177_01_100_1_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_100_1_1_R1.fq.gz
SAMN34331323	E177_01_100_1_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_100_1_1_R1.fq.gz
SAMN34331324	E177_01_100_1_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_100_1_1_R1.fq.gz
SAMN34331325	E177_01_100_1_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_100_1_1_R1.fq.gz
SAMN34331326	E177_01_100_1_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_100_1_1_R1.fq.gz
SAMN34331327	E177_01_100_1_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_100_1_1_R1.fq.gz
SAMN34331328	E177_01_100_1_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_100_1_1_R1.fq.gz
SAMN34331278	E177_01_100_1_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_100_1_1_R1.fq.gz
SAMN34331245	E177_02_100_1_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_100_1_2_R1.fq.gz
SAMN34331329	E177_02_100_1_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_100_1_2_R1.fq.gz
SAMN34331330	E177_02_100_1_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_100_1_2_R1.fq.gz
SAMN34331331	E177_02_100_1_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_100_1_2_R1.fq.gz
SAMN34331332	E177_02_100_1_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_100_1_2_R1.fq.gz
SAMN34331333	E177_02_100_1_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_100_1_2_R1.fq.gz
SAMN34331334	E177_02_100_1_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_100_1_2_R1.fq.gz
SAMN34331335	E177_02_100_1_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_100_1_2_R1.fq.gz
SAMN34331336	E177_02_100_1_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_100_1_2_R1.fq.gz
SAMN34331337	E177_02_100_1_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_100_1_2_R1.fq.gz
SAMN34331338	E177_02_100_1_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_100_1_2_R1.fq.gz
SAMN34331245	E177_02_100_1_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_100_1_2_R1.fq.gz
SAMN34331256	E177_02_100_1_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_100_1_2_R1.fq.gz
SAMN34331339	E177_02_100_1_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_100_1_2_R1.fq.gz
SAMN34331340	E177_02_100_1_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_100_1_2_R1.fq.gz
SAMN34331341	E177_02_100_1_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_100_1_2_R1.fq.gz
SAMN34331342	E177_02_100_1_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_100_1_2_R1.fq.gz
SAMN34331343	E177_02_100_1_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_100_1_2_R1.fq.gz
SAMN34331344	E177_02_100_1_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_100_1_2_R1.fq.gz
SAMN34331345	E177_02_100_1_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_100_1_2_R1.fq.gz
SAMN34331346	E177_02_100_1_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_100_1_2_R1.fq.gz
SAMN34331347	E177_02_100_1_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_100_1_2_R1.fq.gz
SAMN34331348	E177_02_100_1_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_100_1_2_R1.fq.gz
SAMN34331256	E177_02_100_1_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_100_1_2_R1.fq.gz
SAMN34331267	E177_02_100_1_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_100_1_2_R1.fq.gz
SAMN34331349	E177_02_100_1_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_100_1_2_R1.fq.gz
SAMN34331350	E177_02_100_1_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_100_1_2_R1.fq.gz
SAMN34331351	E177_02_100_1_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_100_1_2_R1.fq.gz
SAMN34331352	E177_02_100_1_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_100_1_2_R1.fq.gz
SAMN34331353	E177_02_100_1_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_100_1_2_R1.fq.gz
SAMN34331354	E177_02_100_1_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_100_1_2_R1.fq.gz
SAMN34331355	E177_02_100_1_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_100_1_2_R1.fq.gz
SAMN34331356	E177_02_100_1_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_100_1_2_R1.fq.gz
SAMN34331357	E177_02_100_1_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_100_1_2_R1.fq.gz
SAMN34331358	E177_02_100_1_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_100_1_2_R1.fq.gz
SAMN34331267	E177_02_100_1_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_100_1_2_R1.fq.gz
SAMN34331278	E177_02_100_1_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_100_1_2_R1.fq.gz
SAMN34331359	E177_02_100_1_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_100_1_2_R1.fq.gz
SAMN34331360	E177_02_100_1_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_100_1_2_R1.fq.gz
SAMN34331361	E177_02_100_1_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_100_1_2_R1.fq.gz
SAMN34331362	E177_02_100_1_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_100_1_2_R1.fq.gz
SAMN34331363	E177_02_100_1_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_100_1_2_R1.fq.gz
SAMN34331364	E177_02_100_1_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_100_1_2_R1.fq.gz
SAMN34331365	E177_02_100_1_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_100_1_2_R1.fq.gz
SAMN34331366	E177_02_100_1_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_100_1_2_R1.fq.gz
SAMN34331367	E177_02_100_1_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_100_1_2_R1.fq.gz
SAMN34331368	E177_02_100_1_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_100_1_2_R1.fq.gz
SAMN34331278	E177_02_100_1_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_100_1_2_R1.fq.gz
SAMN34331245	E177_02_100_1_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_100_1_2_R1.fq.gz
SAMN34331369	E177_02_100_1_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_100_1_2_R1.fq.gz
SAMN34331370	E177_02_100_1_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_100_1_2_R1.fq.gz
SAMN34331371	E177_02_100_1_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_100_1_2_R1.fq.gz
SAMN34331372	E177_02_100_1_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_100_1_2_R1.fq.gz
SAMN34331373	E177_02_100_1_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_100_1_2_R1.fq.gz
SAMN34331374	E177_02_100_1_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_100_1_2_R1.fq.gz
SAMN34331375	E177_02_100_1_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_100_1_2_R1.fq.gz
SAMN34331376	E177_02_100_1_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_100_1_2_R1.fq.gz
SAMN34331377	E177_02_100_1_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_100_1_2_R1.fq.gz
SAMN34331378	E177_02_100_1_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_100_1_2_R1.fq.gz
SAMN34331245	E177_02_100_1_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_100_1_2_R1.fq.gz
SAMN34331256	E177_02_100_1_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_100_1_2_R1.fq.gz
SAMN34331379	E177_02_100_1_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_100_1_2_R1.fq.gz
SAMN34331380	E177_02_100_1_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_100_1_2_R1.fq.gz
SAMN34331381	E177_02_100_1_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_100_1_2_R1.fq.gz
SAMN34331382	E177_02_100_1_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_100_1_2_R1.fq.gz
SAMN34331383	E177_02_100_1_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_100_1_2_R1.fq.gz
SAMN34331384	E177_02_100_1_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_100_1_2_R1.fq.gz
SAMN34331385	E177_02_100_1_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_100_1_2_R1.fq.gz
SAMN34331386	E177_02_100_1_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_100_1_2_R1.fq.gz
SAMN34331387	E177_02_100_1_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_100_1_2_R1.fq.gz
SAMN34331388	E177_02_100_1_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_100_1_2_R1.fq.gz
SAMN34331256	E177_02_100_1_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_100_1_2_R1.fq.gz
SAMN34331267	E177_02_100_1_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_100_1_2_R1.fq.gz
SAMN34331389	E177_02_100_1_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_100_1_2_R1.fq.gz
SAMN34331390	E177_02_100_1_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_100_1_2_R1.fq.gz
SAMN34331391	E177_02_100_1_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_100_1_2_R1.fq.gz
SAMN34331392	E177_02_100_1_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_100_1_2_R1.fq.gz
SAMN34331393	E177_02_100_1_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_100_1_2_R1.fq.gz
SAMN34331394	E177_02_100_1_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_100_1_2_R1.fq.gz
SAMN34331395	E177_02_100_1_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_100_1_2_R1.fq.gz
SAMN34331396	E177_02_100_1_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_100_1_2_R1.fq.gz
SAMN34331397	E177_02_100_1_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_100_1_2_R1.fq.gz
SAMN34331398	E177_02_100_1_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_100_1_2_R1.fq.gz
SAMN34331267	E177_02_100_1_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_100_1_2_R1.fq.gz
SAMN34331278	E177_02_100_1_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_100_1_2_R1.fq.gz
SAMN34331399	E177_02_100_1_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_100_1_2_R1.fq.gz
SAMN34331400	E177_02_100_1_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_100_1_2_R1.fq.gz
SAMN34331401	E177_02_100_1_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_100_1_2_R1.fq.gz
SAMN34331402	E177_02_100_1_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_100_1_2_R1.fq.gz
SAMN34331403	E177_02_100_1_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_100_1_2_R1.fq.gz
SAMN34331404	E177_02_100_1_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_100_1_2_R1.fq.gz
SAMN34331405	E177_02_100_1_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_100_1_2_R1.fq.gz
SAMN34331406	E177_02_100_1_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_100_1_2_R1.fq.gz
SAMN34331407	E177_02_100_1_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_100_1_2_R1.fq.gz
SAMN34331408	E177_02_100_1_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_100_1_2_R1.fq.gz
SAMN34331278	E177_02_100_1_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_100_1_2_R1.fq.gz
SAMN34331245	E177_03_100_2_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_100_2_1_R1.fq.gz
SAMN34331246	E177_03_100_2_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_100_2_1_R1.fq.gz
SAMN34331247	E177_03_100_2_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_100_2_1_R1.fq.gz
SAMN34331248	E177_03_100_2_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_100_2_1_R1.fq.gz
SAMN34331249	E177_03_100_2_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_100_2_1_R1.fq.gz
SAMN34331250	E177_03_100_2_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_100_2_1_R1.fq.gz
SAMN34331251	E177_03_100_2_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_100_2_1_R1.fq.gz
SAMN34331252	E177_03_100_2_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_100_2_1_R1.fq.gz
SAMN34331253	E177_03_100_2_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_100_2_1_R1.fq.gz
SAMN34331254	E177_03_100_2_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_100_2_1_R1.fq.gz
SAMN34331255	E177_03_100_2_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_100_2_1_R1.fq.gz
SAMN34331245	E177_03_100_2_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_100_2_1_R1.fq.gz
SAMN34331256	E177_03_100_2_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_100_2_1_R1.fq.gz
SAMN34331257	E177_03_100_2_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_100_2_1_R1.fq.gz
SAMN34331258	E177_03_100_2_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_100_2_1_R1.fq.gz
SAMN34331259	E177_03_100_2_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_100_2_1_R1.fq.gz
SAMN34331260	E177_03_100_2_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_100_2_1_R1.fq.gz
SAMN34331261	E177_03_100_2_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_100_2_1_R1.fq.gz
SAMN34331262	E177_03_100_2_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_100_2_1_R1.fq.gz
SAMN34331263	E177_03_100_2_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_100_2_1_R1.fq.gz
SAMN34331264	E177_03_100_2_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_100_2_1_R1.fq.gz
SAMN34331265	E177_03_100_2_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_100_2_1_R1.fq.gz
SAMN34331266	E177_03_100_2_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_100_2_1_R1.fq.gz
SAMN34331256	E177_03_100_2_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_100_2_1_R1.fq.gz
SAMN34331267	E177_03_100_2_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_100_2_1_R1.fq.gz
SAMN34331268	E177_03_100_2_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_100_2_1_R1.fq.gz
SAMN34331269	E177_03_100_2_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_100_2_1_R1.fq.gz
SAMN34331270	E177_03_100_2_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_100_2_1_R1.fq.gz
SAMN34331271	E177_03_100_2_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_100_2_1_R1.fq.gz
SAMN34331272	E177_03_100_2_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_100_2_1_R1.fq.gz
SAMN34331273	E177_03_100_2_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_100_2_1_R1.fq.gz
SAMN34331274	E177_03_100_2_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_100_2_1_R1.fq.gz
SAMN34331275	E177_03_100_2_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_100_2_1_R1.fq.gz
SAMN34331276	E177_03_100_2_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_100_2_1_R1.fq.gz
SAMN34331277	E177_03_100_2_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_100_2_1_R1.fq.gz
SAMN34331267	E177_03_100_2_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_100_2_1_R1.fq.gz
SAMN34331278	E177_03_100_2_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_100_2_1_R1.fq.gz
SAMN34331279	E177_03_100_2_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_100_2_1_R1.fq.gz
SAMN34331280	E177_03_100_2_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_100_2_1_R1.fq.gz
SAMN34331281	E177_03_100_2_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_100_2_1_R1.fq.gz
SAMN34331282	E177_03_100_2_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_100_2_1_R1.fq.gz
SAMN34331283	E177_03_100_2_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_100_2_1_R1.fq.gz
SAMN34331284	E177_03_100_2_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_100_2_1_R1.fq.gz
SAMN34331285	E177_03_100_2_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_100_2_1_R1.fq.gz
SAMN34331286	E177_03_100_2_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_100_2_1_R1.fq.gz
SAMN34331287	E177_03_100_2_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_100_2_1_R1.fq.gz
SAMN34331288	E177_03_100_2_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_100_2_1_R1.fq.gz
SAMN34331278	E177_03_100_2_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_100_2_1_R1.fq.gz
SAMN34331245	E177_03_100_2_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_100_2_1_R1.fq.gz
SAMN34331289	E177_03_100_2_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_100_2_1_R1.fq.gz
SAMN34331290	E177_03_100_2_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_100_2_1_R1.fq.gz
SAMN34331291	E177_03_100_2_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_100_2_1_R1.fq.gz
SAMN34331292	E177_03_100_2_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_100_2_1_R1.fq.gz
SAMN34331293	E177_03_100_2_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_100_2_1_R1.fq.gz
SAMN34331294	E177_03_100_2_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_100_2_1_R1.fq.gz
SAMN34331295	E177_03_100_2_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_100_2_1_R1.fq.gz
SAMN34331296	E177_03_100_2_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_100_2_1_R1.fq.gz
SAMN34331297	E177_03_100_2_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_100_2_1_R1.fq.gz
SAMN34331298	E177_03_100_2_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_100_2_1_R1.fq.gz
SAMN34331245	E177_03_100_2_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_100_2_1_R1.fq.gz
SAMN34331256	E177_03_100_2_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_100_2_1_R1.fq.gz
SAMN34331299	E177_03_100_2_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_100_2_1_R1.fq.gz
SAMN34331300	E177_03_100_2_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_100_2_1_R1.fq.gz
SAMN34331301	E177_03_100_2_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_100_2_1_R1.fq.gz
SAMN34331302	E177_03_100_2_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_100_2_1_R1.fq.gz
SAMN34331303	E177_03_100_2_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_100_2_1_R1.fq.gz
SAMN34331304	E177_03_100_2_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_100_2_1_R1.fq.gz
SAMN34331305	E177_03_100_2_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_100_2_1_R1.fq.gz
SAMN34331306	E177_03_100_2_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_100_2_1_R1.fq.gz
SAMN34331307	E177_03_100_2_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_100_2_1_R1.fq.gz
SAMN34331308	E177_03_100_2_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_100_2_1_R1.fq.gz
SAMN34331256	E177_03_100_2_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_100_2_1_R1.fq.gz
SAMN34331267	E177_03_100_2_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_100_2_1_R1.fq.gz
SAMN34331309	E177_03_100_2_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_100_2_1_R1.fq.gz
SAMN34331310	E177_03_100_2_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_100_2_1_R1.fq.gz
SAMN34331311	E177_03_100_2_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_100_2_1_R1.fq.gz
SAMN34331312	E177_03_100_2_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_100_2_1_R1.fq.gz
SAMN34331313	E177_03_100_2_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_100_2_1_R1.fq.gz
SAMN34331314	E177_03_100_2_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_100_2_1_R1.fq.gz
SAMN34331315	E177_03_100_2_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_100_2_1_R1.fq.gz
SAMN34331316	E177_03_100_2_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 100 nM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_100_2_1_R1.fq.gz
